###################################################################################################################################################################
#Enrichment results using 'Biological Process from Gene Ontology (GO)', created by dcGO Enrichment at 22/08/2016 13:13:10 (day/month/year hour:min:sec)
#Citation: Fang H, Gough J. (2012) dcGO: database of domain-centric ontologies on functions, phenotypes, diseases and more. Nucleic Acids Res (PubMed ID: 23161684)
###################################################################################################################################################################
#
#'GroupID' column: group id (by default 'Group' for single group);
#'GO ID' column: the identifier of ontological terms;
#'GO term' column: the name of ontological terms;
#'xxxx (four levels)' column: term specificity (only appear when using slim version of the ontology; 1 for highly general, 2 for general, 3 for specific, and 4 for highly specific);
#'Z-score' column: Z-score being calculated based on hypergeometric distribution;
#'P-value' column: P-value being calculated based on hypergeometric distribution;
#'FDR' column: FDR used to assess the statistical significance of term enrichments;
#'#Domains (Overlaps|Group|Term|Background)' column: the number of domains, i.e., 'Overlaps' for the number of domains in the input group but also being annotated by the term; 'Group' for the number of domains in the input group (also annotatable by the ontology); 'Term' for the number of domains being annotated by the term; 'Backgroud' for the number of domains that are annotatable by the ontology.
#'Annotated domains' column: a list of semicolon-separated domains in the input group but also being annotated by the term.
#
GroupID	GO ID	GO term	PFAM slim (four levels)	Z-score	P-value	FDR	#Domains (Overlaps|Group|Term|Background)	Annotated domains
Group	GO:0023051	regulation of signaling	1	11.39	4.01e-22	2.88e-19	77|201|441|3527	PF00014;PF00019;PF00027;PF00040;PF00041;PF00049;PF00057;PF00093;PF00122;PF00130;PF00169;PF00179;PF00240;PF00249;PF00341;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00594;PF00610;PF00611;PF00612;PF00618;PF00640;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00969;PF01030;PF01064;PF01403;PF01404;PF01417;PF01437;PF01448;PF01485;PF01585;PF01699;PF01753;PF01833;PF01843;PF02037;PF02145;PF02148;PF02177;PF02214;PF02377;PF02825;PF03165;PF04055;PF06920;PF07525;PF07645;PF07653;PF07679;PF09324;PF10409;PF12763;PF12783;PF12796;PF12924;PF13414;PF13716;PF13855;PF13920;PF14324;PF14429
Group	GO:0048519	negative regulation of biological process	1	10.52	3.60e-21	1.29e-18	96|201|681|3527	PF00019;PF00023;PF00041;PF00049;PF00057;PF00076;PF00093;PF00098;PF00122;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00241;PF00249;PF00254;PF00341;PF00350;PF00389;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00594;PF00611;PF00622;PF00640;PF00643;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00789;PF00969;PF01030;PF01064;PF01335;PF01403;PF01404;PF01417;PF01448;PF01477;PF01585;PF01699;PF01753;PF01833;PF01909;PF02037;PF02145;PF02148;PF02177;PF02181;PF02201;PF02214;PF02709;PF02826;PF03165;PF04055;PF05773;PF06297;PF07525;PF07645;PF07653;PF07679;PF07719;PF08210;PF08246;PF10277;PF10409;PF10421;PF12348;PF12697;PF12763;PF12796;PF12906;PF12924;PF12947;PF13414;PF13415;PF13716;PF13733;PF13765;PF13854;PF13855;PF13920;PF14324
Group	GO:0043412	macromolecule modification	1	10.36	4.08e-20	9.76e-18	88|201|602|3527	PF00014;PF00019;PF00023;PF00025;PF00027;PF00041;PF00049;PF00076;PF00130;PF00134;PF00169;PF00179;PF00240;PF00249;PF00254;PF00341;PF00383;PF00397;PF00400;PF00415;PF00514;PF00581;PF00583;PF00594;PF00611;PF00622;PF00640;PF00643;PF00651;PF00688;PF00757;PF00780;PF00786;PF00899;PF00989;PF01030;PF01064;PF01404;PF01448;PF01485;PF01585;PF01753;PF02037;PF02148;PF02177;PF02201;PF02214;PF02225;PF02709;PF02825;PF02845;PF02893;PF03133;PF03165;PF03256;PF03607;PF04055;PF04762;PF04810;PF05773;PF06325;PF07645;PF07653;PF07679;PF07707;PF07719;PF08210;PF10277;PF10409;PF11717;PF12697;PF12796;PF12895;PF12906;PF12924;PF13091;PF13344;PF13414;PF13415;PF13646;PF13733;PF13765;PF13831;PF13832;PF13855;PF13920;PF13964;PF14324
Group	GO:0048518	positive regulation of biological process	1	10.20	5.57e-20	1.00e-17	93|201|667|3527	PF00014;PF00019;PF00023;PF00025;PF00027;PF00040;PF00041;PF00049;PF00053;PF00055;PF00057;PF00076;PF00093;PF00098;PF00122;PF00130;PF00133;PF00134;PF00169;PF00179;PF00240;PF00241;PF00249;PF00341;PF00397;PF00400;PF00435;PF00452;PF00514;PF00594;PF00611;PF00612;PF00618;PF00640;PF00643;PF00651;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00969;PF00989;PF01030;PF01064;PF01335;PF01403;PF01404;PF01417;PF01437;PF01448;PF01476;PF01485;PF01585;PF01699;PF01833;PF02037;PF02177;PF02181;PF02825;PF02845;PF03165;PF04055;PF04144;PF05790;PF06367;PF06371;PF07525;PF07534;PF07645;PF07653;PF07679;PF07719;PF08210;PF08246;PF09816;PF10409;PF11717;PF12171;PF12697;PF12756;PF12763;PF12796;PF12924;PF13091;PF13414;PF13716;PF13855;PF13920;PF14324
Group	GO:0048583	regulation of response to stimulus	1	10.25	4.70e-19	6.75e-17	78|201|503|3527	PF00014;PF00019;PF00023;PF00027;PF00040;PF00041;PF00049;PF00057;PF00093;PF00122;PF00130;PF00169;PF00179;PF00240;PF00249;PF00341;PF00397;PF00400;PF00452;PF00514;PF00581;PF00594;PF00610;PF00611;PF00612;PF00618;PF00640;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00969;PF01030;PF01064;PF01217;PF01403;PF01404;PF01417;PF01437;PF01448;PF01476;PF01485;PF01585;PF01753;PF01833;PF01843;PF02037;PF02145;PF02148;PF02177;PF02214;PF02377;PF02825;PF03165;PF04055;PF06920;PF07525;PF07534;PF07645;PF07653;PF07679;PF08246;PF10409;PF12763;PF12796;PF12924;PF13414;PF13716;PF13855;PF13920;PF14324;PF14429
Group	GO:0051128	regulation of cellular component organization	1	10.69	6.99e-19	8.37e-17	62|201|333|3527	PF00019;PF00025;PF00041;PF00049;PF00130;PF00134;PF00169;PF00179;PF00226;PF00241;PF00249;PF00254;PF00341;PF00397;PF00400;PF00435;PF00452;PF00514;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00643;PF00651;PF00688;PF00757;PF00780;PF00786;PF01030;PF01064;PF01403;PF01404;PF01437;PF01833;PF01843;PF02037;PF02145;PF02148;PF02181;PF02893;PF03165;PF06367;PF06371;PF07645;PF07653;PF07679;PF07707;PF07719;PF08210;PF10409;PF12348;PF12796;PF12895;PF12906;PF13091;PF13414;PF13765;PF13855;PF13920
Group	GO:0032879	regulation of localization	1	10.62	1.56e-18	1.60e-16	60|201|318|3527	PF00019;PF00023;PF00027;PF00040;PF00041;PF00045;PF00049;PF00055;PF00076;PF00093;PF00098;PF00122;PF00130;PF00169;PF00254;PF00341;PF00397;PF00400;PF00413;PF00435;PF00452;PF00514;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00969;PF01030;PF01064;PF01217;PF01403;PF01437;PF01833;PF01843;PF02145;PF02214;PF04055;PF04144;PF04810;PF07645;PF07653;PF07679;PF08246;PF10409;PF12697;PF12796;PF13091;PF13716;PF13765;PF13855;PF13903;PF13920
Group	GO:0019538	protein metabolic process	1	9.18	1.31e-17	1.18e-15	104|201|869|3527	PF00014;PF00019;PF00023;PF00025;PF00027;PF00040;PF00041;PF00045;PF00049;PF00057;PF00076;PF00082;PF00122;PF00130;PF00133;PF00134;PF00169;PF00179;PF00226;PF00240;PF00249;PF00254;PF00341;PF00397;PF00400;PF00413;PF00415;PF00452;PF00514;PF00581;PF00583;PF00594;PF00611;PF00612;PF00622;PF00640;PF00643;PF00651;PF00684;PF00688;PF00702;PF00757;PF00780;PF00786;PF00789;PF00899;PF00989;PF01030;PF01064;PF01336;PF01404;PF01448;PF01485;PF01546;PF01753;PF02037;PF02148;PF02177;PF02201;PF02214;PF02225;PF02709;PF02825;PF02845;PF02893;PF03133;PF03165;PF03256;PF03607;PF04055;PF04137;PF04810;PF05773;PF06325;PF07645;PF07653;PF07679;PF07687;PF07707;PF07719;PF08246;PF08662;PF09409;PF10277;PF10409;PF11717;PF12697;PF12796;PF12895;PF12906;PF12924;PF13344;PF13414;PF13415;PF13589;PF13646;PF13733;PF13765;PF13831;PF13832;PF13855;PF13920;PF13964;PF14324
Group	GO:0006928	cellular component movement	1	10.25	2.74e-17	1.79e-15	56|201|296|3527	PF00014;PF00019;PF00041;PF00045;PF00052;PF00053;PF00055;PF00057;PF00130;PF00169;PF00226;PF00241;PF00341;PF00397;PF00400;PF00413;PF00435;PF00594;PF00611;PF00612;PF00618;PF00640;PF00684;PF00688;PF00757;PF00778;PF00786;PF00989;PF01030;PF01064;PF01217;PF01403;PF01404;PF01437;PF01833;PF01843;PF02148;PF02177;PF02181;PF02214;PF03133;PF03607;PF06297;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF07719;PF10409;PF12348;PF12924;PF13414;PF13855;PF14429
Group	GO:0010646	regulation of cell communication	1	10.11	2.70e-17	1.79e-15	60|201|336|3527	PF00019;PF00027;PF00040;PF00041;PF00049;PF00057;PF00093;PF00122;PF00130;PF00169;PF00179;PF00240;PF00249;PF00341;PF00400;PF00435;PF00452;PF00514;PF00581;PF00594;PF00618;PF00640;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00969;PF01030;PF01064;PF01403;PF01417;PF01437;PF01448;PF01485;PF01585;PF01699;PF01833;PF02037;PF02145;PF02214;PF02825;PF03165;PF04055;PF07525;PF07645;PF07653;PF07679;PF10409;PF12763;PF12796;PF13716;PF13855;PF13920;PF14324
Group	GO:0051239	regulation of multicellular organismal process	1	9.70	4.84e-17	2.90e-15	70|201|448|3527	PF00014;PF00019;PF00023;PF00025;PF00027;PF00041;PF00049;PF00076;PF00093;PF00122;PF00130;PF00169;PF00240;PF00249;PF00254;PF00341;PF00400;PF00435;PF00452;PF00514;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00643;PF00651;PF00688;PF00689;PF00690;PF00702;PF00778;PF00780;PF00786;PF00969;PF01064;PF01403;PF01404;PF01417;PF01437;PF01699;PF01753;PF01833;PF01843;PF02037;PF02177;PF02181;PF02214;PF02377;PF03165;PF04055;PF04144;PF06367;PF06371;PF07525;PF07645;PF07653;PF07679;PF08246;PF10409;PF12763;PF12796;PF12924;PF12947;PF13414;PF13716;PF13765;PF13855
Group	GO:0030030	cell projection organization	1	10.26	9.57e-17	5.29e-15	50|201|246|3527	PF00014;PF00019;PF00023;PF00025;PF00041;PF00052;PF00053;PF00055;PF00130;PF00169;PF00341;PF00397;PF00400;PF00415;PF00435;PF00514;PF00581;PF00610;PF00611;PF00612;PF00618;PF00640;PF00651;PF00688;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01403;PF01404;PF01437;PF01833;PF02148;PF02177;PF02377;PF03133;PF03165;PF03607;PF07645;PF07653;PF07679;PF07719;PF12348;PF12796;PF12924;PF13414;PF13716;PF13855
Group	GO:0065008	regulation of biological quality	1	9.15	1.85e-16	9.47e-15	84|201|628|3527	PF00014;PF00019;PF00023;PF00025;PF00027;PF00041;PF00049;PF00057;PF00076;PF00082;PF00093;PF00122;PF00130;PF00153;PF00169;PF00240;PF00241;PF00249;PF00254;PF00341;PF00397;PF00400;PF00435;PF00452;PF00514;PF00583;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00643;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00780;PF00786;PF01064;PF01217;PF01336;PF01403;PF01404;PF01417;PF01437;PF01477;PF01496;PF01553;PF01699;PF01843;PF02037;PF02145;PF02148;PF02177;PF02181;PF02214;PF02225;PF02828;PF02893;PF03165;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF07707;PF08246;PF10409;PF12171;PF12348;PF12756;PF12763;PF12796;PF12924;PF13246;PF13716;PF13855;PF13903;PF14429
Group	GO:0065009	regulation of molecular function	1	9.53	3.28e-16	1.57e-14	64|201|396|3527	PF00014;PF00019;PF00023;PF00025;PF00027;PF00041;PF00049;PF00057;PF00076;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00254;PF00341;PF00397;PF00400;PF00415;PF00452;PF00514;PF00581;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00643;PF00688;PF00757;PF00778;PF00780;PF00786;PF00899;PF01335;PF01403;PF01404;PF01437;PF01585;PF01909;PF02145;PF02148;PF02177;PF02377;PF03165;PF04055;PF06920;PF07525;PF07645;PF07653;PF07679;PF08246;PF09324;PF10421;PF12796;PF12924;PF13716;PF13855;PF13903;PF13920;PF14429
Group	GO:0007399	nervous system development	1	9.51	3.74e-16	1.68e-14	64|201|397|3527	PF00014;PF00019;PF00023;PF00025;PF00041;PF00049;PF00052;PF00053;PF00055;PF00057;PF00122;PF00130;PF00169;PF00249;PF00254;PF00341;PF00397;PF00400;PF00415;PF00435;PF00452;PF00514;PF00610;PF00611;PF00612;PF00618;PF00640;PF00651;PF00688;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01403;PF01404;PF01437;PF01833;PF02145;PF02148;PF02177;PF02181;PF02377;PF03165;PF03607;PF06367;PF06371;PF07525;PF07645;PF07653;PF07679;PF10409;PF12348;PF12796;PF12924;PF13385;PF13414;PF13716;PF13855;PF13903;PF14324
Group	GO:0032990	cell part morphogenesis	1	10.14	5.57e-16	2.35e-14	45|201|210|3527	PF00014;PF00023;PF00025;PF00041;PF00052;PF00053;PF00055;PF00130;PF00169;PF00397;PF00400;PF00415;PF00435;PF00514;PF00581;PF00611;PF00651;PF00688;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01403;PF01404;PF01437;PF01833;PF02148;PF02177;PF02377;PF02893;PF03133;PF03165;PF03607;PF07645;PF07653;PF07679;PF07719;PF12348;PF12796;PF12924;PF13414;PF13716;PF13855
Group	GO:0051641	cellular localization	1	9.18	7.68e-16	3.06e-14	72|201|494|3527	PF00014;PF00019;PF00023;PF00025;PF00027;PF00041;PF00053;PF00076;PF00122;PF00130;PF00153;PF00169;PF00179;PF00226;PF00240;PF00341;PF00350;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00780;PF00786;PF00989;PF01217;PF01403;PF01417;PF01465;PF01843;PF02064;PF02145;PF02177;PF02181;PF02828;PF02893;PF03810;PF04144;PF04695;PF04810;PF07645;PF07653;PF07679;PF07707;PF07719;PF08389;PF09324;PF12171;PF12348;PF12756;PF12763;PF12783;PF12796;PF12924;PF13246;PF13385;PF13414;PF13855;PF13920
Group	GO:0000902	cell morphogenesis	1	9.34	1.19e-14	4.26e-13	49|201|265|3527	PF00014;PF00019;PF00023;PF00025;PF00041;PF00052;PF00053;PF00055;PF00130;PF00169;PF00249;PF00397;PF00400;PF00415;PF00435;PF00514;PF00581;PF00611;PF00640;PF00651;PF00688;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01403;PF01404;PF01437;PF01833;PF01843;PF02148;PF02177;PF02377;PF03133;PF03165;PF03607;PF06920;PF07645;PF07653;PF07679;PF07719;PF12348;PF12796;PF12924;PF13414;PF13716;PF13855
Group	GO:0051674	localization of cell	1	9.42	1.77e-14	6.06e-13	45|201|229|3527	PF00019;PF00041;PF00045;PF00052;PF00053;PF00055;PF00057;PF00130;PF00226;PF00241;PF00341;PF00397;PF00413;PF00435;PF00514;PF00594;PF00611;PF00612;PF00618;PF00640;PF00684;PF00688;PF00757;PF00778;PF01030;PF01064;PF01403;PF01404;PF01437;PF01833;PF02148;PF02214;PF03607;PF06297;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF10409;PF12348;PF13414;PF13855;PF14429
Group	GO:0050793	regulation of developmental process	1	8.64	6.65e-14	2.08e-12	61|201|405|3527	PF00019;PF00025;PF00041;PF00049;PF00057;PF00076;PF00093;PF00098;PF00130;PF00134;PF00169;PF00179;PF00241;PF00249;PF00254;PF00341;PF00400;PF00435;PF00452;PF00514;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00643;PF00651;PF00688;PF00778;PF00780;PF00786;PF01064;PF01403;PF01404;PF01417;PF01437;PF01753;PF01833;PF01843;PF02037;PF02177;PF02181;PF02377;PF03165;PF06367;PF06371;PF07525;PF07645;PF07679;PF08246;PF10409;PF12763;PF12796;PF12906;PF12924;PF12947;PF13414;PF13716;PF13855
Group	GO:0007154	cell communication	1	8.16	7.54e-14	2.26e-12	84|201|691|3527	PF00014;PF00019;PF00023;PF00025;PF00027;PF00041;PF00049;PF00057;PF00076;PF00082;PF00098;PF00122;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00249;PF00341;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00643;PF00651;PF00683;PF00684;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00899;PF00969;PF00989;PF01030;PF01064;PF01217;PF01370;PF01403;PF01404;PF01417;PF01437;PF01465;PF01833;PF01843;PF02140;PF02145;PF02177;PF02214;PF02377;PF02759;PF02825;PF02828;PF03165;PF05773;PF05790;PF07525;PF07645;PF07653;PF07679;PF07707;PF07719;PF08246;PF10277;PF10409;PF12763;PF12796;PF12924;PF13716;PF13855
Group	GO:0009790	embryo development	1	8.85	9.27e-14	2.58e-12	51|201|299|3527	PF00019;PF00025;PF00041;PF00052;PF00053;PF00057;PF00076;PF00093;PF00122;PF00130;PF00133;PF00134;PF00169;PF00249;PF00341;PF00400;PF00435;PF00452;PF00514;PF00583;PF00610;PF00612;PF00622;PF00640;PF00651;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00786;PF00989;PF01030;PF01064;PF01403;PF01417;PF01448;PF01843;PF02145;PF02377;PF02828;PF03165;PF06297;PF07525;PF07645;PF07653;PF07679;PF12796;PF13091;PF13414
Group	GO:0040011	locomotion	1	8.72	1.02e-13	2.71e-12	55|201|342|3527	PF00014;PF00019;PF00041;PF00045;PF00052;PF00053;PF00055;PF00057;PF00098;PF00130;PF00169;PF00226;PF00241;PF00341;PF00397;PF00413;PF00435;PF00514;PF00594;PF00611;PF00612;PF00618;PF00640;PF00651;PF00684;PF00688;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01403;PF01404;PF01437;PF01833;PF02145;PF02148;PF02177;PF02214;PF03165;PF03607;PF06297;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF10409;PF12348;PF12924;PF13414;PF13855;PF14429
Group	GO:0023052	signaling	1	8.08	1.83e-13	4.70e-12	80|201|648|3527	PF00014;PF00019;PF00023;PF00025;PF00027;PF00041;PF00049;PF00057;PF00076;PF00098;PF00122;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00249;PF00341;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00643;PF00651;PF00683;PF00684;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00969;PF00989;PF01030;PF01064;PF01217;PF01370;PF01403;PF01404;PF01417;PF01437;PF01465;PF01833;PF01843;PF02140;PF02145;PF02177;PF02214;PF02377;PF02759;PF02825;PF02828;PF03165;PF05790;PF07525;PF07645;PF07653;PF07679;PF07707;PF07719;PF08246;PF10277;PF10409;PF12763;PF12796;PF12924;PF13716;PF13855
Group	GO:0009605	response to external stimulus	1	8.53	3.49e-13	8.65e-12	53|201|330|3527	PF00014;PF00019;PF00023;PF00027;PF00041;PF00052;PF00053;PF00055;PF00076;PF00082;PF00098;PF00122;PF00341;PF00397;PF00400;PF00435;PF00594;PF00612;PF00618;PF00622;PF00640;PF00651;PF00688;PF00689;PF00690;PF00702;PF00778;PF00780;PF00786;PF00899;PF00969;PF01064;PF01403;PF01404;PF01437;PF01833;PF02145;PF02148;PF02177;PF03165;PF05773;PF06920;PF07645;PF07679;PF08246;PF10409;PF12348;PF12796;PF12924;PF13091;PF13765;PF13855;PF14429
Group	GO:0031323	regulation of cellular metabolic process	1	7.69	5.03e-13	1.16e-11	95|201|867|3527	PF00014;PF00019;PF00023;PF00027;PF00041;PF00049;PF00057;PF00076;PF00098;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00249;PF00254;PF00341;PF00389;PF00397;PF00400;PF00415;PF00435;PF00452;PF00514;PF00581;PF00594;PF00610;PF00611;PF00612;PF00618;PF00640;PF00643;PF00651;PF00688;PF00757;PF00778;PF00780;PF00786;PF00789;PF00899;PF00989;PF01030;PF01064;PF01336;PF01352;PF01403;PF01404;PF01437;PF01448;PF01477;PF01585;PF01753;PF01833;PF02037;PF02145;PF02148;PF02177;PF02201;PF02377;PF02826;PF02845;PF03165;PF04055;PF04762;PF05773;PF06920;PF07525;PF07528;PF07645;PF07653;PF07679;PF07719;PF08210;PF08662;PF09816;PF11717;PF12171;PF12697;PF12756;PF12763;PF12796;PF12895;PF12924;PF13414;PF13415;PF13716;PF13765;PF13831;PF13832;PF13854;PF13855;PF13920;PF14324;PF14429
Group	GO:0080090	regulation of primary metabolic process	1	7.60	9.51e-13	2.07e-11	94|201|861|3527	PF00014;PF00019;PF00023;PF00027;PF00041;PF00049;PF00057;PF00076;PF00098;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00249;PF00341;PF00389;PF00397;PF00400;PF00415;PF00435;PF00452;PF00514;PF00581;PF00594;PF00610;PF00611;PF00612;PF00618;PF00640;PF00643;PF00651;PF00688;PF00757;PF00778;PF00780;PF00786;PF00789;PF00899;PF00989;PF01030;PF01064;PF01335;PF01336;PF01352;PF01403;PF01404;PF01437;PF01448;PF01585;PF01753;PF01833;PF02037;PF02145;PF02148;PF02177;PF02201;PF02377;PF02826;PF02845;PF03165;PF04055;PF04762;PF05773;PF06920;PF07525;PF07528;PF07645;PF07653;PF07679;PF07719;PF08210;PF08662;PF09816;PF11717;PF12171;PF12697;PF12756;PF12763;PF12796;PF12895;PF12924;PF13414;PF13415;PF13716;PF13765;PF13831;PF13832;PF13854;PF13855;PF13920;PF14324;PF14429
Group	GO:0042221	response to chemical stimulus	1	7.84	1.03e-12	2.17e-11	76|201|615|3527	PF00014;PF00019;PF00023;PF00027;PF00040;PF00041;PF00045;PF00049;PF00052;PF00053;PF00055;PF00057;PF00076;PF00093;PF00098;PF00122;PF00130;PF00134;PF00153;PF00169;PF00179;PF00226;PF00240;PF00249;PF00341;PF00397;PF00400;PF00413;PF00435;PF00452;PF00514;PF00583;PF00594;PF00612;PF00622;PF00640;PF00651;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00969;PF00989;PF01030;PF01064;PF01370;PF01403;PF01404;PF01437;PF01833;PF01909;PF02145;PF02148;PF02177;PF03165;PF06920;PF07525;PF07645;PF07653;PF07679;PF07719;PF08246;PF08416;PF10409;PF10421;PF12348;PF12796;PF12924;PF13716;PF13765;PF13855;PF14429
Group	GO:0060255	regulation of macromolecule metabolic process	1	7.34	4.65e-12	9.28e-11	93|201|868|3527	PF00014;PF00019;PF00023;PF00027;PF00041;PF00049;PF00057;PF00076;PF00098;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00249;PF00341;PF00389;PF00397;PF00400;PF00415;PF00435;PF00452;PF00514;PF00581;PF00594;PF00610;PF00640;PF00643;PF00651;PF00688;PF00757;PF00778;PF00780;PF00786;PF00789;PF00899;PF00989;PF01030;PF01064;PF01335;PF01336;PF01352;PF01403;PF01404;PF01437;PF01448;PF01477;PF01585;PF01753;PF01833;PF02037;PF02145;PF02148;PF02177;PF02201;PF02377;PF02826;PF02845;PF03165;PF04055;PF04762;PF05773;PF06325;PF07525;PF07528;PF07645;PF07653;PF07679;PF07719;PF08210;PF08246;PF08662;PF09816;PF10409;PF11717;PF12171;PF12756;PF12763;PF12796;PF12895;PF12924;PF13091;PF13414;PF13415;PF13716;PF13765;PF13831;PF13832;PF13854;PF13855;PF13920;PF14324
Group	GO:0000003	reproduction	1	7.58	2.39e-11	3.98e-10	57|201|412|3527	PF00014;PF00019;PF00041;PF00045;PF00049;PF00053;PF00055;PF00076;PF00098;PF00122;PF00130;PF00134;PF00169;PF00179;PF00188;PF00226;PF00240;PF00249;PF00350;PF00400;PF00413;PF00435;PF00452;PF00514;PF00612;PF00618;PF00622;PF00651;PF00684;PF00688;PF00702;PF00757;PF00780;PF00786;PF00989;PF01030;PF01064;PF01335;PF01465;PF01553;PF01753;PF02037;PF02177;PF02181;PF03165;PF06325;PF07525;PF07653;PF07679;PF09335;PF12478;PF12796;PF12924;PF13091;PF13589;PF13855;PF13920
Group	GO:0007163	establishment or maintenance of cell polarity	1	8.84	3.42e-11	5.45e-10	24|201|88|3527	PF00023;PF00041;PF00052;PF00053;PF00057;PF00130;PF00169;PF00400;PF00435;PF00610;PF00612;PF00651;PF00778;PF00786;PF01404;PF01843;PF02181;PF02828;PF06367;PF06371;PF07653;PF07679;PF12348;PF13855
Group	GO:0051716	cellular response to stimulus	1	7.02	3.55e-11	5.54e-10	90|201|853|3527	PF00014;PF00019;PF00023;PF00025;PF00027;PF00040;PF00041;PF00049;PF00057;PF00076;PF00082;PF00093;PF00098;PF00122;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00249;PF00341;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00583;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00643;PF00651;PF00683;PF00684;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00899;PF00969;PF00989;PF01030;PF01064;PF01336;PF01370;PF01403;PF01404;PF01417;PF01437;PF01833;PF01843;PF01909;PF02037;PF02140;PF02145;PF02177;PF02377;PF02759;PF02825;PF03165;PF05773;PF05790;PF07525;PF07645;PF07653;PF07679;PF07707;PF07719;PF08246;PF10277;PF10409;PF10421;PF11717;PF12763;PF12796;PF12924;PF13589;PF13716;PF13855;PF14324
Group	GO:0051234	establishment of localization	1	7.03	4.60e-11	6.89e-10	85|201|785|3527	PF00014;PF00019;PF00023;PF00025;PF00027;PF00040;PF00041;PF00049;PF00053;PF00057;PF00076;PF00122;PF00130;PF00153;PF00169;PF00179;PF00226;PF00241;PF00249;PF00254;PF00341;PF00350;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00780;PF00989;PF01064;PF01217;PF01417;PF01448;PF01465;PF01477;PF01496;PF01553;PF01699;PF01833;PF01843;PF02064;PF02145;PF02177;PF02214;PF02225;PF02828;PF02893;PF03810;PF04144;PF04695;PF04810;PF06472;PF07645;PF07653;PF07679;PF07707;PF07719;PF08246;PF08389;PF09324;PF10277;PF12763;PF12783;PF12796;PF12924;PF12947;PF13246;PF13347;PF13385;PF13414;PF13415;PF13855
Group	GO:0006950	response to stress	1	6.63	6.22e-10	8.27e-09	77|201|709|3527	PF00019;PF00023;PF00027;PF00040;PF00041;PF00045;PF00049;PF00057;PF00076;PF00082;PF00093;PF00098;PF00122;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00249;PF00341;PF00350;PF00400;PF00413;PF00435;PF00452;PF00581;PF00594;PF00618;PF00622;PF00640;PF00643;PF00651;PF00684;PF00688;PF00689;PF00690;PF00702;PF00757;PF00780;PF00786;PF00899;PF00969;PF00989;PF01030;PF01336;PF01404;PF01476;PF01477;PF01833;PF01843;PF01909;PF02037;PF02145;PF02177;PF04055;PF05773;PF05790;PF06920;PF07534;PF07645;PF07653;PF07679;PF08246;PF10277;PF10409;PF10421;PF11717;PF12697;PF12924;PF12947;PF13589;PF13716;PF13765;PF13855;PF14324;PF14429
Group	GO:0033036	macromolecule localization	1	6.97	9.22e-10	1.16e-08	49|201|354|3527	PF00019;PF00023;PF00025;PF00041;PF00052;PF00053;PF00057;PF00076;PF00122;PF00130;PF00169;PF00226;PF00240;PF00241;PF00350;PF00397;PF00400;PF00435;PF00514;PF00581;PF00611;PF00683;PF00688;PF00778;PF01064;PF01217;PF01465;PF01477;PF02064;PF02145;PF02828;PF03810;PF04144;PF04695;PF04810;PF06472;PF07645;PF07653;PF07679;PF08389;PF10277;PF10409;PF12348;PF12763;PF12796;PF13246;PF13414;PF13415;PF13855
Group	GO:0051171	regulation of nitrogen compound metabolic process	1	6.40	2.73e-09	3.16e-08	71|201|647|3527	PF00019;PF00023;PF00027;PF00041;PF00049;PF00076;PF00098;PF00130;PF00134;PF00169;PF00179;PF00226;PF00249;PF00341;PF00389;PF00397;PF00400;PF00435;PF00514;PF00610;PF00611;PF00612;PF00618;PF00643;PF00651;PF00688;PF00757;PF00780;PF00899;PF00989;PF01030;PF01336;PF01352;PF01403;PF01404;PF01437;PF01448;PF01585;PF01753;PF01833;PF02037;PF02145;PF02177;PF02201;PF02826;PF03165;PF04762;PF06920;PF07528;PF07645;PF07653;PF07679;PF07719;PF08210;PF09816;PF11717;PF12171;PF12756;PF12796;PF12895;PF12924;PF13414;PF13415;PF13716;PF13831;PF13832;PF13854;PF13855;PF13920;PF14324;PF14429
Group	GO:0002376	immune system process	1	5.45	9.23e-07	6.25e-06	41|201|334|3527	PF00019;PF00023;PF00041;PF00057;PF00130;PF00153;PF00169;PF00179;PF00240;PF00249;PF00254;PF00341;PF00350;PF00452;PF00514;PF00594;PF00612;PF00643;PF00651;PF00688;PF00780;PF00969;PF01335;PF01404;PF01476;PF01909;PF02037;PF04055;PF04810;PF05790;PF07534;PF07645;PF07653;PF07679;PF08246;PF10409;PF10421;PF12697;PF12796;PF13855;PF14324
Group	GO:0044260	cellular macromolecule metabolic process	1	4.85	1.13e-06	7.61e-06	114|201|1425|3527	PF00014;PF00019;PF00023;PF00025;PF00027;PF00041;PF00049;PF00057;PF00076;PF00082;PF00098;PF00122;PF00130;PF00133;PF00134;PF00169;PF00179;PF00226;PF00240;PF00249;PF00254;PF00341;PF00383;PF00397;PF00400;PF00415;PF00452;PF00514;PF00581;PF00583;PF00594;PF00611;PF00622;PF00640;PF00643;PF00651;PF00684;PF00688;PF00702;PF00757;PF00780;PF00786;PF00789;PF00899;PF00989;PF01030;PF01064;PF01336;PF01370;PF01404;PF01448;PF01480;PF01485;PF01585;PF01753;PF01909;PF02037;PF02148;PF02177;PF02201;PF02214;PF02225;PF02709;PF02825;PF02845;PF02878;PF02893;PF03133;PF03165;PF03256;PF03607;PF03828;PF04055;PF04137;PF04762;PF04810;PF05485;PF05773;PF06325;PF07034;PF07528;PF07645;PF07653;PF07679;PF07707;PF07719;PF08075;PF08210;PF08662;PF09409;PF10277;PF10409;PF11717;PF12171;PF12697;PF12796;PF12895;PF12906;PF12924;PF13091;PF13344;PF13414;PF13415;PF13589;PF13646;PF13691;PF13733;PF13765;PF13831;PF13832;PF13855;PF13920;PF13964;PF14324
Group	GO:0009056	catabolic process	1	4.64	1.14e-05	6.06e-05	54|201|543|3527	PF00019;PF00025;PF00049;PF00082;PF00098;PF00122;PF00134;PF00153;PF00179;PF00205;PF00226;PF00240;PF00350;PF00383;PF00397;PF00400;PF00452;PF00456;PF00583;PF00612;PF00622;PF00643;PF00688;PF00689;PF00690;PF00702;PF00789;PF00899;PF00970;PF01370;PF01477;PF01485;PF01546;PF01597;PF01909;PF02148;PF02214;PF02825;PF02845;PF03256;PF03828;PF06472;PF07707;PF08210;PF08246;PF08442;PF09409;PF10409;PF12697;PF12895;PF13414;PF13589;PF13646;PF13920
Group	GO:0009889	regulation of biosynthetic process	1	4.35	2.83e-05	1.34e-04	60|201|646|3527	PF00014;PF00019;PF00023;PF00049;PF00076;PF00098;PF00130;PF00134;PF00169;PF00179;PF00249;PF00341;PF00389;PF00397;PF00400;PF00435;PF00514;PF00643;PF00651;PF00688;PF00757;PF00899;PF00989;PF01030;PF01064;PF01336;PF01352;PF01448;PF01585;PF01753;PF01833;PF02037;PF02177;PF02201;PF02826;PF03165;PF04762;PF05773;PF07528;PF07645;PF07679;PF07719;PF08210;PF08662;PF09816;PF11717;PF12171;PF12756;PF12796;PF12895;PF12924;PF13414;PF13415;PF13716;PF13831;PF13832;PF13854;PF13855;PF13920;PF14324
Group	GO:0001932	regulation of protein phosphorylation	2	11.01	1.97e-17	1.57e-15	42|201|169|3527	PF00014;PF00019;PF00023;PF00027;PF00041;PF00049;PF00057;PF00134;PF00169;PF00226;PF00240;PF00341;PF00400;PF00415;PF00452;PF00581;PF00594;PF00610;PF00640;PF00688;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01403;PF01437;PF01585;PF02145;PF02177;PF02377;PF04055;PF07525;PF07645;PF07653;PF07679;PF12796;PF12924;PF13716;PF13855;PF13920
Group	GO:0016477	cell migration	2	9.92	4.08e-15	1.54e-13	41|201|185|3527	PF00019;PF00041;PF00045;PF00052;PF00053;PF00055;PF00057;PF00130;PF00341;PF00397;PF00413;PF00435;PF00594;PF00611;PF00612;PF00618;PF00640;PF00688;PF00757;PF00778;PF01030;PF01064;PF01403;PF01404;PF01437;PF01833;PF02148;PF02214;PF03607;PF06297;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF10409;PF12348;PF13414;PF13855;PF14429
Group	GO:0035556	intracellular signal transduction	2	9.64	1.89e-14	6.16e-13	40|201|184|3527	PF00025;PF00027;PF00041;PF00049;PF00098;PF00122;PF00130;PF00134;PF00169;PF00240;PF00397;PF00400;PF00435;PF00452;PF00581;PF00610;PF00611;PF00612;PF00618;PF00640;PF00643;PF00651;PF00689;PF00690;PF00702;PF00780;PF00786;PF01843;PF02145;PF02759;PF07525;PF07645;PF07653;PF07679;PF08246;PF10277;PF10409;PF12763;PF13716;PF13855
Group	GO:0060541	respiratory system development	2	10.28	9.33e-14	2.58e-12	26|201|82|3527	PF00019;PF00041;PF00045;PF00049;PF00057;PF00130;PF00240;PF00341;PF00413;PF00435;PF00640;PF00688;PF01064;PF02037;PF02181;PF02828;PF03165;PF06367;PF06371;PF07645;PF07653;PF07679;PF08246;PF10409;PF13855;PF13903
Group	GO:0032446	protein modification by small protein conjugation	2	9.52	4.29e-13	1.03e-11	30|201|116|3527	PF00023;PF00179;PF00240;PF00397;PF00415;PF00514;PF00622;PF00643;PF00651;PF00899;PF01485;PF02037;PF02148;PF02201;PF02214;PF02225;PF02825;PF02845;PF03256;PF05773;PF07707;PF07719;PF12796;PF12895;PF12906;PF13414;PF13765;PF13920;PF13964;PF14324
Group	GO:0051130	positive regulation of cellular component organization	2	9.48	9.50e-13	2.07e-11	28|201|104|3527	PF00019;PF00025;PF00041;PF00241;PF00249;PF00341;PF00397;PF00400;PF00452;PF00514;PF00594;PF00611;PF00688;PF00786;PF01064;PF01403;PF01404;PF01437;PF02181;PF03165;PF06367;PF06371;PF07653;PF07679;PF07719;PF12796;PF13091;PF13855
Group	GO:0007444	imaginal disc development	2	9.57	2.59e-12	5.31e-11	24|201|79|3527	PF00023;PF00041;PF00045;PF00076;PF00130;PF00397;PF00413;PF00435;PF00612;PF00651;PF01064;PF01448;PF01476;PF01833;PF02037;PF03165;PF07534;PF07645;PF07653;PF07679;PF12796;PF13855;PF13920;PF14324
Group	GO:0043549	regulation of kinase activity	2	8.82	5.29e-12	1.03e-10	31|201|135|3527	PF00014;PF00019;PF00023;PF00027;PF00041;PF00049;PF00134;PF00169;PF00240;PF00341;PF00400;PF00415;PF00581;PF00640;PF00688;PF00778;PF00780;PF00786;PF01585;PF02145;PF02177;PF04055;PF07525;PF07645;PF07653;PF07679;PF12796;PF12924;PF13716;PF13855;PF13920
Group	GO:0018193	peptidyl-amino acid modification	2	8.66	6.47e-12	1.22e-10	33|201|153|3527	PF00041;PF00130;PF00169;PF00240;PF00249;PF00254;PF00341;PF00397;PF00400;PF00581;PF00583;PF00594;PF00611;PF00757;PF00899;PF01030;PF01404;PF01753;PF02709;PF03133;PF04810;PF06325;PF07645;PF07679;PF07719;PF11717;PF12796;PF13414;PF13646;PF13733;PF13831;PF13832;PF13855
Group	GO:0051056	regulation of small GTPase mediated signal transduction	2	9.47	7.61e-12	1.40e-10	22|201|69|3527	PF00041;PF00130;PF00169;PF00610;PF00611;PF00612;PF00618;PF00651;PF00780;PF01403;PF01404;PF01437;PF01833;PF02145;PF02214;PF06920;PF07653;PF07679;PF12796;PF13716;PF13855;PF14429
Group	GO:0030198	extracellular matrix organization	2	9.55	8.89e-12	1.60e-10	21|201|63|3527	PF00019;PF00023;PF00041;PF00045;PF00052;PF00053;PF00055;PF00057;PF00093;PF00397;PF00413;PF00640;PF00688;PF02177;PF02709;PF04810;PF07679;PF12924;PF13716;PF13733;PF13855
Group	GO:0031329	regulation of cellular catabolic process	2	8.77	1.40e-11	2.44e-10	28|201|115|3527	PF00027;PF00041;PF00076;PF00130;PF00169;PF00226;PF00240;PF00400;PF00514;PF00610;PF00611;PF00612;PF00618;PF00778;PF00780;PF00789;PF01403;PF01404;PF01437;PF02145;PF02148;PF06920;PF07653;PF12697;PF13414;PF13716;PF13855;PF14429
Group	GO:0042060	wound healing	2	9.07	1.51e-11	2.58e-10	24|201|85|3527	PF00027;PF00041;PF00093;PF00122;PF00130;PF00169;PF00341;PF00435;PF00594;PF00618;PF00622;PF00643;PF00689;PF00690;PF00702;PF00757;PF00786;PF01030;PF06920;PF07653;PF07679;PF13716;PF13765;PF14429
Group	GO:0006461	protein complex assembly	2	8.17	3.24e-11	5.29e-10	35|201|180|3527	PF00019;PF00025;PF00041;PF00093;PF00130;PF00134;PF00169;PF00179;PF00350;PF00400;PF00452;PF00611;PF00622;PF00643;PF00688;PF00757;PF00778;PF00969;PF01030;PF01064;PF02148;PF02181;PF02214;PF02893;PF03165;PF04695;PF06309;PF06367;PF06371;PF07645;PF07679;PF07719;PF12763;PF12947;PF13765
Group	GO:0010740	positive regulation of intracellular protein kinase cascade	2	9.01	3.67e-11	5.60e-10	22|201|74|3527	PF00019;PF00041;PF00049;PF00122;PF00130;PF00179;PF00240;PF00341;PF00594;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF01030;PF01485;PF07653;PF07679;PF12763;PF13920
Group	GO:0006508	proteolysis	2	7.87	1.27e-10	1.87e-09	34|201|179|3527	PF00040;PF00045;PF00057;PF00076;PF00082;PF00134;PF00179;PF00226;PF00240;PF00397;PF00400;PF00413;PF00452;PF00594;PF00612;PF00622;PF00643;PF00789;PF01485;PF01546;PF02148;PF02214;PF02225;PF02825;PF02845;PF03256;PF07687;PF07707;PF08246;PF12895;PF13414;PF13589;PF13646;PF13920
Group	GO:0051301	cell division	2	8.34	2.00e-10	2.87e-09	24|201|95|3527	PF00019;PF00025;PF00076;PF00130;PF00134;PF00169;PF00241;PF00350;PF00435;PF00452;PF00514;PF00612;PF00640;PF00651;PF00688;PF00780;PF00786;PF01064;PF02181;PF03165;PF06367;PF06371;PF07707;PF13964
Group	GO:0002165	instar larval or pupal development	2	8.43	2.62e-10	3.69e-09	22|201|81|3527	PF00023;PF00045;PF00076;PF00130;PF00397;PF00413;PF00435;PF00514;PF00612;PF00651;PF01064;PF01448;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF10409;PF12796;PF13855;PF13920
Group	GO:0007552	metamorphosis	2	8.50	2.79e-10	3.86e-09	21|201|74|3527	PF00023;PF00045;PF00076;PF00130;PF00397;PF00413;PF00435;PF00612;PF00651;PF01064;PF01448;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF10409;PF12796;PF13855;PF13920
Group	GO:0032270	positive regulation of cellular protein metabolic process	2	7.82	4.04e-10	5.47e-09	29|201|140|3527	PF00019;PF00041;PF00049;PF00057;PF00076;PF00134;PF00179;PF00240;PF00249;PF00341;PF00400;PF00594;PF00640;PF00688;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF02845;PF07645;PF07653;PF07679;PF07719;PF12763;PF13414;PF13855;PF14324
Group	GO:0021700	developmental maturation	2	8.34	6.69e-10	8.74e-09	20|201|70|3527	PF00014;PF00019;PF00041;PF00076;PF00130;PF00134;PF00169;PF00435;PF00622;PF00651;PF00688;PF01833;PF01843;PF02177;PF07525;PF07679;PF12796;PF12924;PF13091;PF13855
Group	GO:0009968	negative regulation of signal transduction	2	7.55	7.72e-10	9.90e-09	31|201|162|3527	PF00019;PF00041;PF00049;PF00057;PF00093;PF00130;PF00169;PF00249;PF00400;PF00514;PF00581;PF00640;PF00651;PF00683;PF00688;PF00778;PF01448;PF01585;PF01833;PF02037;PF02145;PF02214;PF03165;PF07525;PF07645;PF07679;PF10409;PF12763;PF12796;PF13855;PF14324
Group	GO:0006468	protein phosphorylation	2	7.64	9.74e-10	1.21e-08	28|201|136|3527	PF00014;PF00019;PF00027;PF00041;PF00049;PF00130;PF00134;PF00169;PF00240;PF00341;PF00611;PF00640;PF00688;PF00757;PF00780;PF00786;PF00989;PF01030;PF01064;PF01404;PF02177;PF03165;PF03607;PF07645;PF07653;PF07679;PF12924;PF13855
Group	GO:0060341	regulation of cellular localization	2	7.54	1.16e-09	1.41e-08	29|201|146|3527	PF00019;PF00023;PF00027;PF00076;PF00098;PF00169;PF00514;PF00594;PF00610;PF00612;PF00618;PF00622;PF00688;PF00757;PF00778;PF00969;PF01030;PF01064;PF01833;PF01843;PF02214;PF04055;PF04144;PF04810;PF12796;PF13091;PF13716;PF13765;PF13855
Group	GO:0009886	post-embryonic morphogenesis	2	7.91	1.50e-09	1.80e-08	22|201|88|3527	PF00023;PF00045;PF00076;PF00130;PF00397;PF00413;PF00435;PF00452;PF00612;PF00651;PF01064;PF01448;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF10409;PF12796;PF13855;PF13920
Group	GO:0051235	maintenance of location	2	8.80	1.96e-09	2.30e-08	14|201|35|3527	PF00023;PF00122;PF00241;PF00400;PF00435;PF00683;PF00689;PF00690;PF00702;PF07645;PF12171;PF12348;PF12756;PF12796
Group	GO:0001763	morphogenesis of a branching structure	2	7.99	2.79e-09	3.18e-08	19|201|68|3527	PF00019;PF00045;PF00049;PF00130;PF00341;PF00413;PF00435;PF00688;PF00786;PF01064;PF01403;PF01404;PF01437;PF01833;PF07645;PF07653;PF07679;PF08246;PF13855
Group	GO:0048569	post-embryonic organ development	2	7.70	2.99e-09	3.35e-08	22|201|91|3527	PF00023;PF00045;PF00076;PF00130;PF00249;PF00397;PF00413;PF00435;PF00452;PF00612;PF00651;PF01064;PF01448;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF12796;PF13855;PF13920
Group	GO:0046903	secretion	2	7.35	6.14e-09	6.78e-08	24|201|111|3527	PF00019;PF00023;PF00025;PF00027;PF00041;PF00122;PF00130;PF00169;PF00341;PF00610;PF00612;PF00618;PF00640;PF00683;PF00688;PF00702;PF01217;PF01417;PF01553;PF02828;PF04144;PF07645;PF07679;PF12763
Group	GO:0007411	axon guidance	2	7.53	8.79e-09	9.57e-08	20|201|80|3527	PF00014;PF00041;PF00052;PF00397;PF00435;PF00651;PF00778;PF00780;PF01064;PF01403;PF01404;PF01437;PF01833;PF02148;PF02177;PF03165;PF07645;PF07679;PF12924;PF13855
Group	GO:0030163	protein catabolic process	2	7.24	8.96e-09	9.60e-08	24|201|113|3527	PF00082;PF00134;PF00179;PF00226;PF00240;PF00397;PF00400;PF00452;PF00622;PF00643;PF00789;PF01485;PF02148;PF02214;PF02825;PF02845;PF03256;PF07707;PF09409;PF12895;PF13414;PF13589;PF13646;PF13920
Group	GO:0030900	forebrain development	2	7.46	1.11e-08	1.17e-07	20|201|81|3527	PF00014;PF00019;PF00041;PF00057;PF00249;PF00640;PF00688;PF00757;PF01030;PF01064;PF01404;PF02177;PF03165;PF03607;PF07645;PF07679;PF12924;PF13414;PF13716;PF13855
Group	GO:0048737	imaginal disc-derived appendage development	2	7.72	1.20e-08	1.25e-07	17|201|59|3527	PF00023;PF00076;PF00130;PF00397;PF00435;PF00612;PF00651;PF01064;PF01448;PF01476;PF01833;PF03165;PF07534;PF07645;PF12796;PF13855;PF13920
Group	GO:0051241	negative regulation of multicellular organismal process	2	7.54	1.49e-08	1.53e-07	18|201|67|3527	PF00019;PF00041;PF00122;PF00169;PF00240;PF00341;PF00594;PF00651;PF00688;PF00689;PF00690;PF00702;PF00969;PF01699;PF07525;PF07645;PF10409;PF12796
Group	GO:0060560	developmental growth involved in morphogenesis	2	7.63	1.59e-08	1.61e-07	17|201|60|3527	PF00014;PF00019;PF00041;PF00057;PF00130;PF00688;PF00786;PF01064;PF01843;PF02177;PF02828;PF03607;PF07653;PF07679;PF12796;PF12924;PF13855
Group	GO:0030097	hemopoiesis	2	7.05	2.14e-08	2.14e-07	23|201|109|3527	PF00019;PF00023;PF00041;PF00130;PF00153;PF00169;PF00249;PF00341;PF00452;PF00514;PF00612;PF00643;PF00651;PF00688;PF00780;PF02037;PF04055;PF05790;PF07645;PF07679;PF12796;PF13855;PF14324
Group	GO:0007268	synaptic transmission	2	6.81	2.36e-08	2.32e-07	27|201|146|3527	PF00014;PF00025;PF00041;PF00122;PF00130;PF00169;PF00435;PF00622;PF00640;PF00651;PF00690;PF00786;PF01064;PF01217;PF01404;PF01417;PF02177;PF02214;PF02828;PF03165;PF07653;PF07679;PF07707;PF12763;PF12796;PF12924;PF13855
Group	GO:0035239	tube morphogenesis	2	6.99	2.57e-08	2.50e-07	23|201|110|3527	PF00019;PF00045;PF00049;PF00130;PF00341;PF00400;PF00413;PF00435;PF00514;PF00651;PF00688;PF00786;PF00989;PF01403;PF01437;PF02145;PF03165;PF07653;PF07679;PF07707;PF08246;PF13414;PF13855
Group	GO:0035107	appendage morphogenesis	2	7.05	3.19e-08	3.05e-07	21|201|94|3527	PF00023;PF00057;PF00076;PF00130;PF00397;PF00435;PF00452;PF00612;PF00651;PF01064;PF01448;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF07719;PF12796;PF13855;PF13920
Group	GO:1900542	regulation of purine nucleotide metabolic process	2	7.11	3.35e-08	3.17e-07	20|201|86|3527	PF00027;PF00041;PF00130;PF00169;PF00226;PF00514;PF00610;PF00611;PF00612;PF00618;PF00780;PF01403;PF01404;PF01437;PF02145;PF06920;PF07653;PF13716;PF13855;PF14429
Group	GO:0010769	regulation of cell morphogenesis involved in differentiation	2	7.35	3.56e-08	3.32e-07	17|201|63|3527	PF00019;PF00041;PF00435;PF00514;PF00688;PF00780;PF01403;PF01404;PF01437;PF01833;PF02181;PF03165;PF06367;PF06371;PF07679;PF13414;PF13855
Group	GO:0016358	dendrite development	2	7.57	3.65e-08	3.36e-07	15|201|49|3527	PF00014;PF00041;PF00053;PF00435;PF00640;PF00780;PF00786;PF01064;PF01404;PF02177;PF03607;PF07653;PF07679;PF12796;PF12924
Group	GO:0051345	positive regulation of hydrolase activity	2	6.99	3.89e-08	3.53e-07	21|201|95|3527	PF00019;PF00025;PF00041;PF00130;PF00169;PF00226;PF00452;PF00514;PF00610;PF00611;PF00612;PF00643;PF00688;PF01404;PF02145;PF06920;PF07679;PF08246;PF13716;PF13920;PF14429
Group	GO:0010975	regulation of neuron projection development	2	7.27	4.61e-08	4.14e-07	17|201|64|3527	PF00025;PF00041;PF00254;PF00435;PF00611;PF00780;PF01403;PF01404;PF01437;PF01833;PF02181;PF06367;PF06371;PF07679;PF10409;PF12796;PF13855
Group	GO:0008544	epidermis development	2	6.98	8.09e-08	7.17e-07	18|201|74|3527	PF00019;PF00023;PF00093;PF00122;PF00249;PF00400;PF00514;PF00612;PF00622;PF00688;PF00689;PF00702;PF00757;PF01030;PF01843;PF07679;PF12796;PF13855
Group	GO:0034330	cell junction organization	2	7.01	9.67e-08	8.47e-07	17|201|67|3527	PF00019;PF00041;PF00052;PF00053;PF00055;PF00130;PF00169;PF00435;PF00514;PF00640;PF00688;PF00786;PF02828;PF07645;PF07653;PF07679;PF13903
Group	GO:0051640	organelle localization	2	6.70	1.01e-07	8.61e-07	21|201|100|3527	PF00130;PF00169;PF00350;PF00400;PF00435;PF00612;PF00640;PF00651;PF00780;PF00786;PF01403;PF01843;PF02181;PF02893;PF04810;PF07707;PF07719;PF12171;PF12756;PF13414;PF13920
Group	GO:0007346	regulation of mitotic cell cycle	2	6.70	1.01e-07	8.61e-07	21|201|100|3527	PF00014;PF00019;PF00076;PF00130;PF00134;PF00341;PF00397;PF00452;PF00640;PF00688;PF01448;PF02037;PF02148;PF02177;PF07653;PF07679;PF12796;PF12895;PF12924;PF13414;PF14324
Group	GO:0008360	regulation of cell shape	2	6.98	1.42e-07	1.20e-06	16|201|61|3527	PF00130;PF00169;PF00341;PF00611;PF00612;PF00618;PF00780;PF00786;PF01403;PF01437;PF01843;PF02181;PF06367;PF06371;PF07679;PF10409
Group	GO:0016049	cell growth	2	7.05	1.55e-07	1.29e-06	15|201|54|3527	PF00014;PF00041;PF00130;PF00651;PF00786;PF01064;PF01843;PF02177;PF03607;PF07679;PF07707;PF12796;PF12924;PF13716;PF13855
Group	GO:0051347	positive regulation of transferase activity	2	6.76	1.56e-07	1.29e-06	18|201|77|3527	PF00019;PF00041;PF00049;PF00057;PF00134;PF00169;PF00240;PF00341;PF00400;PF00640;PF00688;PF00778;PF00780;PF00786;PF07645;PF07653;PF07679;PF13855
Group	GO:0023061	signal release	2	6.89	1.82e-07	1.47e-06	16|201|62|3527	PF00019;PF00023;PF00025;PF00027;PF00130;PF00169;PF00610;PF00618;PF00640;PF00683;PF00688;PF01217;PF01417;PF02828;PF07645;PF12763
Group	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2	6.64	1.82e-07	1.47e-06	19|201|86|3527	PF00019;PF00041;PF00049;PF00130;PF00169;PF00341;PF00618;PF00640;PF00688;PF00757;PF01030;PF01404;PF02145;PF07525;PF07645;PF07653;PF07679;PF10409;PF13855
Group	GO:0051248	negative regulation of protein metabolic process	2	6.38	1.97e-07	1.57e-06	23|201|122|3527	PF00019;PF00023;PF00041;PF00076;PF00098;PF00134;PF00226;PF00240;PF00400;PF00452;PF00581;PF00688;PF00789;PF01335;PF01585;PF02145;PF02148;PF05773;PF07525;PF12796;PF13716;PF13765;PF13920
Group	GO:2000145	regulation of cell motility	2	6.47	2.06e-07	1.62e-06	21|201|104|3527	PF00019;PF00041;PF00045;PF00055;PF00093;PF00130;PF00341;PF00413;PF00688;PF00757;PF01030;PF01403;PF01437;PF01833;PF07645;PF07653;PF07679;PF08246;PF10409;PF13716;PF13855
Group	GO:0001558	regulation of cell growth	2	6.70	2.42e-07	1.85e-06	17|201|71|3527	PF00019;PF00041;PF00134;PF00179;PF00226;PF00435;PF00640;PF00643;PF00688;PF00757;PF01030;PF01403;PF01437;PF07679;PF10409;PF12796;PF13855
Group	GO:0044087	regulation of cellular component biogenesis	2	6.42	2.44e-07	1.85e-06	21|201|105|3527	PF00025;PF00041;PF00130;PF00241;PF00249;PF00341;PF00400;PF00452;PF00611;PF00612;PF00622;PF00786;PF01064;PF01404;PF02181;PF03165;PF06367;PF06371;PF07653;PF10409;PF12796
Group	GO:0001654	eye development	2	6.37	2.41e-07	1.85e-06	22|201|114|3527	PF00019;PF00041;PF00053;PF00130;PF00400;PF00415;PF00452;PF00514;PF00612;PF00618;PF00651;PF00688;PF01064;PF01404;PF01843;PF02037;PF03607;PF07679;PF10409;PF13716;PF13920;PF14324
Group	GO:0042176	regulation of protein catabolic process	2	7.10	2.68e-07	2.00e-06	13|201|42|3527	PF00240;PF00397;PF00400;PF00514;PF00778;PF00789;PF01335;PF02037;PF02148;PF07525;PF13414;PF13920;PF14324
Group	GO:0010562	positive regulation of phosphorus metabolic process	2	6.31	4.06e-07	3.00e-06	20|201|99|3527	PF00019;PF00041;PF00049;PF00057;PF00134;PF00240;PF00341;PF00594;PF00640;PF00688;PF00778;PF00780;PF00786;PF01064;PF01403;PF07645;PF07653;PF07679;PF12763;PF13855
Group	GO:0044057	regulation of system process	2	6.17	4.54e-07	3.33e-06	22|201|118|3527	PF00019;PF00027;PF00041;PF00122;PF00130;PF00169;PF00254;PF00341;PF00435;PF00514;PF00618;PF00688;PF00689;PF00690;PF00702;PF01699;PF01833;PF02214;PF07653;PF07679;PF12796;PF13855
Group	GO:0051494	negative regulation of cytoskeleton organization	2	6.92	6.17e-07	4.48e-06	12|201|38|3527	PF00041;PF00241;PF00254;PF00400;PF00435;PF00514;PF00622;PF00643;PF07653;PF12348;PF12796;PF13765
Group	GO:0043408	regulation of MAPK cascade	2	6.29	6.36e-07	4.56e-06	18|201|84|3527	PF00049;PF00130;PF00169;PF00341;PF00397;PF00514;PF00581;PF00640;PF00757;PF00778;PF00780;PF00786;PF01030;PF01404;PF01843;PF07653;PF07679;PF13855
Group	GO:0007292	female gamete generation	2	6.34	6.93e-07	4.93e-06	17|201|76|3527	PF00076;PF00130;PF00134;PF00350;PF00435;PF00514;PF00612;PF00618;PF00622;PF00651;PF01064;PF03165;PF07525;PF07653;PF07679;PF13091;PF13920
Group	GO:0071310	cellular response to organic substance	2	5.65	7.51e-07	5.29e-06	33|201|237|3527	PF00019;PF00041;PF00049;PF00076;PF00093;PF00098;PF00130;PF00169;PF00179;PF00226;PF00240;PF00249;PF00341;PF00400;PF00452;PF00514;PF00583;PF00622;PF00640;PF00688;PF00757;PF00969;PF01030;PF01064;PF01909;PF03165;PF07525;PF07653;PF07679;PF07719;PF10409;PF10421;PF13855
Group	GO:0007610	behavior	2	5.88	7.64e-07	5.32e-06	25|201|151|3527	PF00014;PF00027;PF00057;PF00076;PF00122;PF00130;PF00397;PF00435;PF00612;PF00640;PF00651;PF00689;PF00690;PF00702;PF00970;PF00989;PF01465;PF01699;PF02177;PF02214;PF07653;PF12796;PF12924;PF13716;PF13855
Group	GO:0080135	regulation of cellular response to stress	2	6.17	9.21e-07	6.25e-06	18|201|86|3527	PF00023;PF00040;PF00041;PF00049;PF00169;PF00179;PF00397;PF00452;PF00640;PF00778;PF00780;PF00786;PF01404;PF01753;PF01843;PF02037;PF07653;PF13855
Group	GO:0031532	actin cytoskeleton reorganization	2	7.37	1.51e-06	9.95e-06	8|201|17|3527	PF00122;PF00130;PF00612;PF00640;PF00689;PF00690;PF00702;PF00780
Group	GO:0003002	regionalization	2	5.75	1.50e-06	9.95e-06	23|201|136|3527	PF00019;PF00041;PF00057;PF00076;PF00093;PF00130;PF00249;PF00400;PF00514;PF00612;PF00622;PF00651;PF00688;PF00778;PF01064;PF01448;PF02377;PF03165;PF06297;PF07525;PF07679;PF12796;PF13091
Group	GO:0045597	positive regulation of cell differentiation	2	5.93	1.57e-06	1.01e-05	19|201|98|3527	PF00019;PF00041;PF00093;PF00098;PF00130;PF00341;PF00400;PF00514;PF00640;PF00688;PF01064;PF01403;PF01437;PF03165;PF07525;PF07645;PF07679;PF12796;PF13855
Group	GO:0051240	positive regulation of multicellular organismal process	2	5.93	1.57e-06	1.01e-05	19|201|98|3527	PF00019;PF00027;PF00122;PF00130;PF00169;PF00341;PF00594;PF00688;PF00689;PF00690;PF00702;PF01064;PF01699;PF04055;PF07645;PF07679;PF12796;PF13716;PF13855
Group	GO:0050817	coagulation	2	6.18	1.72e-06	1.10e-05	15|201|64|3527	PF00027;PF00041;PF00093;PF00122;PF00130;PF00169;PF00341;PF00594;PF00618;PF00689;PF00690;PF00702;PF06920;PF07679;PF14429
Group	GO:0008038	neuron recognition	2	6.94	2.16e-06	1.33e-05	9|201|23|3527	PF00014;PF00041;PF00435;PF00651;PF01404;PF01437;PF02177;PF07679;PF12924
Group	GO:0030031	cell projection assembly	2	6.19	2.12e-06	1.33e-05	14|201|57|3527	PF00041;PF00169;PF00341;PF00400;PF00581;PF00610;PF00612;PF00778;PF01833;PF02377;PF03133;PF03607;PF07719;PF13414
Group	GO:0060627	regulation of vesicle-mediated transport	2	6.19	2.12e-06	1.33e-05	14|201|57|3527	PF00169;PF00341;PF00397;PF00400;PF00594;PF00610;PF00611;PF00618;PF01833;PF02145;PF04144;PF07645;PF13091;PF13920
Group	GO:0032535	regulation of cellular component size	2	6.10	2.12e-06	1.33e-05	15|201|65|3527	PF00041;PF00130;PF00169;PF00241;PF00400;PF00435;PF00786;PF01403;PF01437;PF02145;PF02181;PF07653;PF07679;PF10409;PF13855
Group	GO:0016569	covalent chromatin modification	2	5.72	2.17e-06	1.33e-05	21|201|119|3527	PF00076;PF00130;PF00134;PF00179;PF00249;PF00254;PF00397;PF00400;PF00583;PF00622;PF01448;PF01753;PF02148;PF06325;PF07719;PF11717;PF12796;PF13414;PF13415;PF13831;PF13832
Group	GO:0009798	axis specification	2	6.05	4.01e-06	2.40e-05	13|201|52|3527	PF00057;PF00076;PF00130;PF00400;PF00612;PF00622;PF00651;PF00778;PF01064;PF03165;PF06297;PF07525;PF13091
Group	GO:0051051	negative regulation of transport	2	5.94	4.09e-06	2.43e-05	14|201|60|3527	PF00019;PF00023;PF00130;PF00397;PF00400;PF00611;PF00622;PF00688;PF01064;PF01833;PF04055;PF12796;PF13716;PF13765
Group	GO:0010564	regulation of cell cycle process	2	5.49	4.33e-06	2.55e-05	21|201|124|3527	PF00019;PF00076;PF00130;PF00134;PF00240;PF00341;PF00397;PF00400;PF00452;PF00514;PF00640;PF00688;PF01336;PF01448;PF02037;PF02148;PF07679;PF12796;PF12895;PF13414;PF14324
Group	GO:0007600	sensory perception	2	5.59	4.96e-06	2.89e-05	18|201|96|3527	PF00023;PF00027;PF00053;PF00055;PF00122;PF00350;PF00415;PF00612;PF00689;PF00690;PF00702;PF01477;PF03607;PF07653;PF07679;PF07719;PF12796;PF13385
Group	GO:0042981	regulation of apoptotic process	2	5.10	6.06e-06	3.51e-05	31|201|236|3527	PF00019;PF00041;PF00049;PF00082;PF00130;PF00169;PF00240;PF00341;PF00397;PF00452;PF00514;PF00594;PF00640;PF00643;PF00688;PF00757;PF01030;PF01064;PF01335;PF01404;PF01585;PF02037;PF07653;PF07679;PF08246;PF10277;PF10409;PF12763;PF13716;PF13855;PF13920
Group	GO:0031110	regulation of microtubule polymerization or depolymerization	2	6.26	6.19e-06	3.55e-05	10|201|32|3527	PF00025;PF00041;PF00254;PF00435;PF00514;PF00622;PF00643;PF12348;PF12796;PF13765
Group	GO:0034762	regulation of transmembrane transport	2	5.58	7.17e-06	4.08e-05	16|201|80|3527	PF00019;PF00023;PF00254;PF00341;PF00397;PF00514;PF00622;PF00688;PF00757;PF00778;PF01030;PF07653;PF12796;PF13716;PF13855;PF13903
Group	GO:0045786	negative regulation of cell cycle	2	5.70	9.73e-06	5.50e-05	13|201|56|3527	PF00019;PF00023;PF00134;PF00350;PF00397;PF00640;PF00688;PF01477;PF02148;PF07645;PF07653;PF07679;PF10409
Group	GO:0050878	regulation of body fluid levels	2	5.46	1.00e-05	5.54e-05	16|201|82|3527	PF00027;PF00041;PF00093;PF00122;PF00130;PF00169;PF00341;PF00594;PF00618;PF00689;PF00690;PF00702;PF01553;PF06920;PF07679;PF14429
Group	GO:0000278	mitotic cell cycle	2	5.20	1.06e-05	5.69e-05	21|201|131|3527	PF00014;PF00019;PF00023;PF00130;PF00134;PF00179;PF00400;PF00452;PF00581;PF00688;PF00780;PF01336;PF01833;PF02037;PF02148;PF02177;PF07679;PF12348;PF12895;PF12924;PF14324
Group	GO:0048610	cellular process involved in reproduction	2	4.99	1.17e-05	6.10e-05	27|201|197|3527	PF00019;PF00041;PF00076;PF00098;PF00130;PF00134;PF00179;PF00240;PF00350;PF00435;PF00452;PF00612;PF00622;PF00651;PF00688;PF00786;PF01064;PF01753;PF03165;PF06325;PF07525;PF07653;PF07679;PF12796;PF13091;PF13589;PF13920
Group	GO:0009416	response to light stimulus	2	5.19	1.24e-05	6.39e-05	20|201|122|3527	PF00014;PF00023;PF00057;PF00076;PF00098;PF00122;PF00134;PF00226;PF00249;PF00400;PF00452;PF00689;PF00690;PF00702;PF00989;PF02037;PF02177;PF12924;PF13716;PF13855
Group	GO:0044265	cellular macromolecule catabolic process	2	4.97	1.33e-05	6.78e-05	26|201|187|3527	PF00082;PF00098;PF00134;PF00179;PF00226;PF00240;PF00397;PF00400;PF00452;PF00622;PF00643;PF00789;PF01485;PF01909;PF02148;PF02214;PF02825;PF02845;PF03256;PF03828;PF07707;PF12895;PF13414;PF13589;PF13646;PF13920
Group	GO:0030155	regulation of cell adhesion	2	5.34	1.38e-05	7.00e-05	16|201|84|3527	PF00019;PF00041;PF00093;PF00130;PF00169;PF00341;PF00612;PF00651;PF00688;PF01064;PF01404;PF07645;PF07653;PF07679;PF10409;PF13716
Group	GO:0043269	regulation of ion transport	2	5.23	1.89e-05	9.50e-05	16|201|86|3527	PF00122;PF00169;PF00254;PF00341;PF00397;PF00435;PF00452;PF00514;PF00594;PF00622;PF00689;PF00690;PF00702;PF07653;PF12796;PF13903
Group	GO:0048638	regulation of developmental growth	2	5.28	2.31e-05	1.13e-04	14|201|69|3527	PF00019;PF00134;PF00179;PF00435;PF00611;PF00612;PF00622;PF00688;PF01064;PF01403;PF01437;PF03165;PF07679;PF13855
Group	GO:0007283	spermatogenesis	2	5.21	2.31e-05	1.13e-04	15|201|78|3527	PF00041;PF00179;PF00226;PF00240;PF00350;PF00452;PF00612;PF00651;PF00684;PF00780;PF01753;PF02037;PF07679;PF12796;PF13091
Group	GO:2000027	regulation of organ morphogenesis	2	5.31	2.62e-05	1.27e-04	13|201|61|3527	PF00019;PF00400;PF00452;PF00514;PF00610;PF00640;PF00688;PF00778;PF01064;PF02377;PF03165;PF07679;PF12796
Group	GO:0045596	negative regulation of cell differentiation	2	4.96	2.69e-05	1.30e-04	19|201|118|3527	PF00019;PF00098;PF00249;PF00514;PF00688;PF00778;PF00780;PF01064;PF01403;PF01404;PF01417;PF02177;PF03165;PF07645;PF07679;PF12796;PF12924;PF13414;PF13716
Group	GO:0030705	cytoskeleton-dependent intracellular transport	2	5.46	2.87e-05	1.35e-04	11|201|45|3527	PF00014;PF00169;PF00400;PF00435;PF00612;PF00989;PF01217;PF02177;PF07719;PF12924;PF13414
Group	GO:0032880	regulation of protein localization	2	5.09	3.16e-05	1.47e-04	15|201|80|3527	PF00019;PF00023;PF00514;PF00622;PF00688;PF00757;PF00778;PF00969;PF01030;PF04055;PF04144;PF12796;PF13716;PF13765;PF13855
Group	GO:0043069	negative regulation of programmed cell death	2	4.90	3.54e-05	1.63e-04	18|201|110|3527	PF00019;PF00041;PF00049;PF00130;PF00169;PF00341;PF00452;PF00594;PF00688;PF00757;PF01030;PF02037;PF07653;PF08246;PF10277;PF12763;PF13855;PF13920
Group	GO:0007015	actin filament organization	2	5.16	3.78e-05	1.73e-04	13|201|63|3527	PF00241;PF00400;PF00611;PF00612;PF01064;PF01417;PF02181;PF02214;PF06367;PF06371;PF07653;PF10409;PF12796
Group	GO:0048511	rhythmic process	2	5.20	4.22e-05	1.89e-04	12|201|55|3527	PF00019;PF00027;PF00041;PF00076;PF00098;PF00249;PF00452;PF00583;PF00688;PF00989;PF07679;PF13716
Group	GO:0032970	regulation of actin filament-based process	2	5.20	4.22e-05	1.89e-04	12|201|55|3527	PF00041;PF00130;PF00169;PF00241;PF00400;PF00610;PF00611;PF00786;PF01404;PF02181;PF07653;PF12796
Group	GO:0043244	regulation of protein complex disassembly	2	5.69	4.52e-05	2.00e-04	8|201|25|3527	PF00041;PF00241;PF00435;PF00514;PF00622;PF00643;PF12348;PF13765
Group	GO:0001822	kidney development	2	5.02	4.50e-05	2.00e-04	14|201|73|3527	PF00019;PF00025;PF00041;PF00240;PF00341;PF00400;PF00452;PF00612;PF00651;PF00688;PF07679;PF07707;PF08246;PF13716
Group	GO:0012501	programmed cell death	2	4.70	4.69e-05	2.07e-04	21|201|144|3527	PF00014;PF00027;PF00130;PF00240;PF00452;PF00514;PF00651;PF00757;PF00786;PF00989;PF01030;PF01335;PF01404;PF02177;PF07653;PF08246;PF10409;PF12924;PF13716;PF13855;PF13920
Group	GO:0051050	positive regulation of transport	2	4.85	5.22e-05	2.24e-04	16|201|93|3527	PF00019;PF00040;PF00049;PF00076;PF00169;PF00341;PF00397;PF00400;PF00452;PF00594;PF00688;PF00969;PF04144;PF12796;PF13091;PF13855
Group	GO:0001568	blood vessel development	2	4.80	5.25e-05	2.25e-04	17|201|103|3527	PF00019;PF00093;PF00169;PF00341;PF00618;PF00640;PF00688;PF01064;PF01403;PF01404;PF01437;PF01833;PF02037;PF07645;PF07679;PF12796;PF13716
Group	GO:0050890	cognition	2	4.97	7.37e-05	3.01e-04	12|201|58|3527	PF00014;PF00057;PF00122;PF00397;PF00689;PF00690;PF00702;PF01699;PF02177;PF07653;PF12924;PF13716
Group	GO:0019216	regulation of lipid metabolic process	2	4.88	7.47e-05	3.03e-04	13|201|67|3527	PF00019;PF00041;PF00049;PF00098;PF00169;PF00341;PF00400;PF00688;PF07653;PF07679;PF07719;PF12697;PF13414
Group	GO:0006357	regulation of transcription from RNA polymerase II promoter	2	4.42	8.97e-05	3.62e-04	23|201|173|3527	PF00019;PF00023;PF00049;PF00400;PF00435;PF00514;PF00651;PF00688;PF00989;PF01833;PF02037;PF02177;PF02201;PF03165;PF04762;PF07645;PF07679;PF12796;PF12924;PF13415;PF13716;PF13854;PF13920
Group	GO:0007219	Notch signaling pathway	2	5.13	1.02e-04	4.10e-04	9|201|35|3527	PF00023;PF00400;PF01370;PF01417;PF01833;PF01843;PF02825;PF07645;PF12796
Group	GO:0007018	microtubule-based movement	2	4.82	1.05e-04	4.17e-04	12|201|60|3527	PF00014;PF00169;PF00400;PF00435;PF00612;PF00989;PF01217;PF02177;PF03133;PF07719;PF12924;PF13414
Group	GO:0051216	cartilage development	2	5.00	1.06e-04	4.19e-04	10|201|43|3527	PF00019;PF00052;PF00053;PF00057;PF00093;PF00688;PF01064;PF03165;PF07645;PF07679
Group	GO:0006898	receptor-mediated endocytosis	2	5.24	1.12e-04	4.39e-04	8|201|28|3527	PF00040;PF00057;PF00169;PF00350;PF00397;PF00611;PF07645;PF12947
Group	GO:0051325	interphase	2	4.69	1.20e-04	4.66e-04	13|201|70|3527	PF00014;PF00019;PF00023;PF00134;PF00452;PF00581;PF00688;PF01336;PF01833;PF02037;PF02177;PF12924;PF14324
Group	GO:0008285	negative regulation of cell proliferation	2	4.51	1.29e-04	4.98e-04	16|201|100|3527	PF00019;PF00350;PF00514;PF00688;PF00786;PF00969;PF01753;PF02145;PF02709;PF03165;PF06297;PF07679;PF07719;PF10409;PF13716;PF13733
Group	GO:0001701	in utero embryonic development	2	4.76	1.44e-04	5.47e-04	11|201|53|3527	PF00169;PF00249;PF00341;PF00640;PF00757;PF00989;PF01030;PF01064;PF01417;PF03165;PF07679
Group	GO:0048732	gland development	2	4.55	1.48e-04	5.58e-04	14|201|81|3527	PF00041;PF00049;PF00122;PF00341;PF00514;PF00702;PF00757;PF00989;PF01030;PF01403;PF01553;PF07679;PF10409;PF13716
Group	GO:0008283	cell proliferation	2	4.29	1.59e-04	5.95e-04	20|201|145|3527	PF00019;PF00027;PF00041;PF00076;PF00130;PF00134;PF00249;PF00254;PF00341;PF00452;PF00640;PF00688;PF01064;PF01404;PF02148;PF03165;PF05485;PF07653;PF07679;PF10409
Group	GO:0001817	regulation of cytokine production	2	4.49	1.69e-04	6.30e-04	14|201|82|3527	PF00019;PF00023;PF00076;PF00130;PF00240;PF00622;PF00651;PF00688;PF00969;PF04055;PF04144;PF12796;PF13765;PF13855
Group	GO:0033365	protein localization to organelle	2	4.36	1.74e-04	6.42e-04	17|201|113|3527	PF00019;PF00025;PF00226;PF00240;PF00350;PF00397;PF00435;PF00514;PF00688;PF02064;PF02145;PF03810;PF04695;PF07645;PF08389;PF12796;PF13414
Group	GO:0044092	negative regulation of molecular function	2	4.26	1.75e-04	6.45e-04	20|201|146|3527	PF00041;PF00076;PF00134;PF00169;PF00254;PF00397;PF00400;PF00452;PF00581;PF00594;PF00688;PF01585;PF02145;PF02148;PF07525;PF07653;PF09324;PF12796;PF13716;PF13920
Group	GO:0045165	cell fate commitment	2	4.37	1.85e-04	6.77e-04	16|201|103|3527	PF00019;PF00076;PF00130;PF00249;PF00435;PF00651;PF00688;PF00989;PF01064;PF01465;PF02828;PF03165;PF07645;PF07653;PF07679;PF10409
Group	GO:0001738	morphogenesis of a polarized epithelium	2	4.97	1.91e-04	6.95e-04	8|201|30|3527	PF00053;PF00130;PF00514;PF00612;PF00651;PF01843;PF02828;PF06297
Group	GO:0050678	regulation of epithelial cell proliferation	2	4.61	2.04e-04	7.29e-04	11|201|55|3527	PF00019;PF00041;PF00130;PF00341;PF00514;PF00688;PF00757;PF01030;PF01064;PF03165;PF07679
Group	GO:0070482	response to oxygen levels	2	4.61	2.04e-04	7.29e-04	11|201|55|3527	PF00019;PF00023;PF00045;PF00341;PF00413;PF00643;PF00688;PF00989;PF02037;PF02145;PF13716
Group	GO:0034621	cellular macromolecular complex subunit organization	2	4.14	2.10e-04	7.47e-04	22|201|171|3527	PF00019;PF00025;PF00041;PF00076;PF00130;PF00134;PF00169;PF00179;PF00241;PF00400;PF00583;PF00611;PF00688;PF01064;PF01585;PF02181;PF03165;PF06325;PF06367;PF06371;PF07679;PF07719
Group	GO:0051052	regulation of DNA metabolic process	2	4.45	2.16e-04	7.64e-04	13|201|74|3527	PF00019;PF00134;PF00179;PF00249;PF00341;PF00651;PF00688;PF01336;PF02037;PF07679;PF12171;PF12756;PF12895
Group	GO:0007369	gastrulation	2	4.54	2.41e-04	8.42e-04	11|201|56|3527	PF00019;PF00025;PF00076;PF00130;PF00435;PF00583;PF00688;PF00778;PF01064;PF03165;PF06297
Group	GO:0050776	regulation of immune response	2	4.23	2.41e-04	8.42e-04	17|201|116|3527	PF00023;PF00041;PF00057;PF00130;PF00169;PF00179;PF00240;PF00611;PF00651;PF00969;PF01476;PF04055;PF07534;PF07645;PF07679;PF08246;PF13855
Group	GO:0010942	positive regulation of cell death	2	4.19	2.68e-04	9.19e-04	17|201|117|3527	PF00019;PF00041;PF00169;PF00240;PF00397;PF00452;PF00514;PF00643;PF00688;PF01335;PF01404;PF01585;PF07653;PF07679;PF08246;PF10409;PF13716
Group	GO:0045765	regulation of angiogenesis	2	4.55	2.81e-04	9.60e-04	10|201|48|3527	PF00041;PF00093;PF00130;PF00169;PF00341;PF00643;PF07645;PF08246;PF12947;PF13716
Group	GO:0030111	regulation of Wnt receptor signaling pathway	2	4.46	2.85e-04	9.68e-04	11|201|57|3527	PF00019;PF00041;PF00057;PF00400;PF00514;PF00612;PF00688;PF00778;PF02825;PF07679;PF12796
Group	GO:0036075	replacement ossification	2	5.07	3.31e-04	1.11e-03	6|201|18|3527	PF00019;PF00052;PF00053;PF00057;PF00688;PF07679
Group	GO:0016337	cell-cell adhesion	2	4.47	3.35e-04	1.11e-03	10|201|49|3527	PF00041;PF00122;PF00169;PF00514;PF00688;PF00689;PF00690;PF00702;PF07679;PF13855
Group	GO:0006909	phagocytosis	2	4.47	3.35e-04	1.11e-03	10|201|49|3527	PF00041;PF00053;PF00057;PF00130;PF00249;PF00400;PF01217;PF01448;PF07645;PF07679
Group	GO:0051046	regulation of secretion	2	4.16	3.48e-04	1.14e-03	15|201|98|3527	PF00019;PF00027;PF00040;PF00169;PF00610;PF00618;PF00622;PF00688;PF00969;PF01064;PF01833;PF02214;PF04055;PF04144;PF13765
Group	GO:0009725	response to hormone stimulus	2	4.00	3.82e-04	1.24e-03	19|201|143|3527	PF00019;PF00041;PF00045;PF00049;PF00130;PF00169;PF00249;PF00413;PF00452;PF00514;PF00640;PF00688;PF00757;PF01030;PF01064;PF07525;PF07653;PF10409;PF13855
Group	GO:0030855	epithelial cell differentiation	2	4.23	4.18e-04	1.35e-03	12|201|69|3527	PF00019;PF00041;PF00049;PF00130;PF00514;PF00612;PF00640;PF00688;PF01064;PF03165;PF07645;PF07679
Group	GO:0055123	digestive system development	2	4.42	4.56e-04	1.47e-03	9|201|42|3527	PF00019;PF00041;PF00049;PF00400;PF00688;PF00757;PF01030;PF03165;PF07679
Group	GO:1901214	regulation of neuron death	2	4.32	4.72e-04	1.50e-03	10|201|51|3527	PF00041;PF00082;PF00169;PF00452;PF01404;PF07653;PF07679;PF12763;PF13716;PF13855
Group	GO:0032844	regulation of homeostatic process	2	4.17	4.79e-04	1.52e-03	12|201|70|3527	PF00019;PF00041;PF00057;PF00179;PF00249;PF00254;PF00452;PF00622;PF00688;PF00969;PF12796;PF13716
Group	GO:0030003	cellular cation homeostasis	2	3.98	4.95e-04	1.56e-03	16|201|112|3527	PF00014;PF00041;PF00122;PF00130;PF00254;PF00400;PF00452;PF00622;PF00689;PF00690;PF00702;PF01496;PF01699;PF02177;PF02225;PF12924
Group	GO:0045199	maintenance of epithelial cell apical/basal polarity	2	5.41	5.98e-04	1.79e-03	4|201|8|3527	PF00052;PF00053;PF00057;PF07679
Group	GO:0072347	response to anesthetic	2	5.41	5.98e-04	1.79e-03	4|201|8|3527	PF00052;PF00053;PF00057;PF07679
Group	GO:0045893	positive regulation of transcription, DNA-dependent	2	3.83	5.95e-04	1.79e-03	19|201|148|3527	PF00019;PF00023;PF00400;PF00435;PF00514;PF00688;PF00757;PF00989;PF01030;PF01833;PF02037;PF02177;PF03165;PF07645;PF08210;PF09816;PF12796;PF12924;PF13716
Group	GO:0072507	divalent inorganic cation homeostasis	2	4.06	6.25e-04	1.86e-03	12|201|72|3527	PF00041;PF00122;PF00130;PF00254;PF00452;PF00622;PF00689;PF00690;PF00702;PF01699;PF02177;PF12924
Group	GO:0006836	neurotransmitter transport	2	4.25	6.56e-04	1.93e-03	9|201|44|3527	PF00122;PF00130;PF00169;PF00640;PF00690;PF01217;PF01417;PF02828;PF12763
Group	GO:0008213	protein alkylation	2	4.25	6.56e-04	1.93e-03	9|201|44|3527	PF00076;PF00134;PF00400;PF00622;PF01753;PF06325;PF07719;PF12796;PF13414
Group	GO:0017038	protein import	2	4.06	7.02e-04	2.01e-03	11|201|63|3527	PF00019;PF00226;PF00400;PF00514;PF00688;PF02064;PF02145;PF03810;PF04695;PF07645;PF12796
Group	GO:0040017	positive regulation of locomotion	2	4.09	7.60e-04	2.14e-03	10|201|54|3527	PF00019;PF00053;PF00055;PF00093;PF00130;PF00169;PF00341;PF00688;PF07679;PF08246
Group	GO:0043122	regulation of I-kappaB kinase/NF-kappaB cascade	2	4.16	7.80e-04	2.18e-03	9|201|45|3527	PF00122;PF00179;PF00240;PF00689;PF00690;PF00702;PF01485;PF12796;PF13920
Group	GO:0034220	ion transmembrane transport	2	4.00	8.06e-04	2.24e-03	11|201|64|3527	PF00023;PF00027;PF00122;PF00153;PF00452;PF00622;PF00690;PF00702;PF01699;PF02214;PF12796
Group	GO:0002684	positive regulation of immune system process	2	3.75	8.92e-04	2.45e-03	16|201|118|3527	PF00023;PF00041;PF00057;PF00130;PF00169;PF00179;PF00240;PF00611;PF00651;PF00969;PF01476;PF04055;PF05790;PF07534;PF07645;PF13855
Group	GO:0007548	sex differentiation	2	3.89	9.14e-04	2.50e-03	12|201|75|3527	PF00019;PF00041;PF00076;PF00098;PF00134;PF00400;PF00452;PF00651;PF00688;PF00989;PF01064;PF07679
Group	GO:0045926	negative regulation of growth	2	4.08	9.23e-04	2.52e-03	9|201|46|3527	PF00019;PF00226;PF00611;PF00622;PF00640;PF00643;PF00688;PF01403;PF10409
Group	GO:0030001	metal ion transport	2	3.70	9.39e-04	2.55e-03	17|201|130|3527	PF00023;PF00027;PF00041;PF00122;PF00153;PF00254;PF00622;PF00651;PF00689;PF00690;PF00702;PF01699;PF01833;PF02214;PF02225;PF07707;PF12796
Group	GO:0048678	response to axon injury	2	4.63	1.07e-03	2.78e-03	5|201|15|3527	PF00041;PF00452;PF07645;PF07679;PF13855
Group	GO:0016055	Wnt receptor signaling pathway	2	4.10	1.07e-03	2.78e-03	8|201|38|3527	PF00049;PF00057;PF00435;PF00514;PF00610;PF00778;PF02377;PF07707
Group	GO:0060249	anatomical structure homeostasis	2	3.72	1.22e-03	3.13e-03	13|201|88|3527	PF00041;PF00082;PF00249;PF00397;PF00435;PF00452;PF00514;PF01336;PF02037;PF02893;PF07679;PF08246;PF12796
Group	GO:0072511	divalent inorganic cation transport	2	3.71	1.54e-03	3.86e-03	11|201|69|3527	PF00023;PF00041;PF00122;PF00254;PF00622;PF00689;PF00690;PF00702;PF01699;PF01833;PF12796
Group	GO:0043583	ear development	2	3.78	1.72e-03	4.17e-03	9|201|50|3527	PF00049;PF00122;PF00400;PF00689;PF00690;PF00702;PF07645;PF07679;PF13385
Group	GO:0002252	immune effector process	2	3.53	1.85e-03	4.45e-03	13|201|92|3527	PF00041;PF00057;PF00130;PF00969;PF01404;PF01909;PF04055;PF07645;PF07679;PF08246;PF10409;PF10421;PF13855
Group	GO:0045927	positive regulation of growth	2	3.63	2.02e-03	4.80e-03	10|201|61|3527	PF00133;PF00169;PF00612;PF00757;PF00989;PF01030;PF01064;PF03165;PF12796;PF13716
Group	GO:0061326	renal tubule development	2	3.86	2.11e-03	5.00e-03	7|201|33|3527	PF00400;PF00651;PF01064;PF07679;PF07707;PF12796;PF13414
Group	GO:0071495	cellular response to endogenous stimulus	2	3.38	2.15e-03	5.07e-03	16|201|128|3527	PF00019;PF00041;PF00049;PF00093;PF00169;PF00249;PF00452;PF00640;PF00688;PF00757;PF01030;PF01064;PF07653;PF07679;PF10409;PF13855
Group	GO:0032101	regulation of response to external stimulus	2	3.45	2.26e-03	5.32e-03	13|201|94|3527	PF00019;PF00027;PF00041;PF00130;PF00341;PF00594;PF00688;PF01403;PF01437;PF01833;PF07653;PF07679;PF13855
Group	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	2	3.67	2.49e-03	5.66e-03	8|201|43|3527	PF00019;PF00093;PF00683;PF00688;PF01064;PF03165;PF07645;PF12796
Group	GO:0060348	bone development	2	3.67	2.49e-03	5.66e-03	8|201|43|3527	PF00019;PF00052;PF00053;PF00057;PF00622;PF00688;PF07645;PF07679
Group	GO:0060173	limb development	2	3.67	2.49e-03	5.66e-03	8|201|43|3527	PF00019;PF00057;PF00452;PF00688;PF01448;PF03165;PF07679;PF07719
Group	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	2	3.67	2.49e-03	5.66e-03	8|201|43|3527	PF00019;PF00341;PF00397;PF00683;PF00688;PF01064;PF03165;PF07645
Group	GO:0010608	posttranscriptional regulation of gene expression	2	3.34	2.49e-03	5.66e-03	15|201|118|3527	PF00014;PF00019;PF00076;PF00098;PF00240;PF00643;PF00757;PF01030;PF02148;PF02177;PF05773;PF08246;PF08662;PF10409;PF12924
Group	GO:0031099	regeneration	2	4.05	2.66e-03	6.01e-03	5|201|18|3527	PF00041;PF00757;PF01030;PF07645;PF13855
Group	GO:0006605	protein targeting	2	3.27	2.95e-03	6.63e-03	15|201|120|3527	PF00019;PF00226;PF00397;PF00435;PF00514;PF00688;PF02064;PF02145;PF03810;PF04695;PF07645;PF08389;PF12796;PF13414;PF13855
Group	GO:0045892	negative regulation of transcription, DNA-dependent	2	3.24	2.96e-03	6.64e-03	16|201|132|3527	PF00179;PF00389;PF00400;PF00514;PF00651;PF00688;PF01448;PF01585;PF02201;PF02826;PF07679;PF12796;PF13414;PF13415;PF13854;PF13920
Group	GO:0007422	peripheral nervous system development	2	3.67	3.01e-03	6.74e-03	7|201|35|3527	PF00019;PF00041;PF00169;PF00757;PF01030;PF07679;PF13716
Group	GO:0007009	plasma membrane organization	2	3.58	3.56e-03	7.64e-03	7|201|36|3527	PF00169;PF00435;PF00611;PF00622;PF00643;PF12796;PF13765
Group	GO:0060485	mesenchyme development	2	3.31	4.37e-03	9.34e-03	9|201|57|3527	PF00019;PF00688;PF00757;PF01030;PF01064;PF01403;PF01833;PF07645;PF07679
Group	GO:0048705	skeletal system morphogenesis	2	3.37	4.44e-03	9.43e-03	8|201|47|3527	PF00019;PF00052;PF00053;PF00057;PF00688;PF03165;PF07645;PF07679
Group	GO:0051897	positive regulation of protein kinase B signaling cascade	3	8.32	2.17e-07	1.69e-06	8|201|14|3527	PF00019;PF00049;PF00594;PF00688;PF00757;PF01030;PF07653;PF12763
Group	GO:0043551	regulation of phosphatidylinositol 3-kinase activity	3	7.66	8.41e-07	5.80e-06	8|201|16|3527	PF00019;PF00041;PF00049;PF00169;PF00341;PF00688;PF07653;PF07679
Group	GO:0008542	visual learning	3	7.50	2.26e-06	1.37e-05	7|201|13|3527	PF00014;PF00122;PF00689;PF00690;PF00702;PF02177;PF12924
Group	GO:0045822	negative regulation of heart contraction	3	8.21	3.28e-06	1.98e-05	5|201|6|3527	PF00122;PF00169;PF00689;PF00690;PF00702
Group	GO:0032472	Golgi calcium ion transport	3	8.14	1.03e-05	5.54e-05	4|201|4|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0048840	otolith development	3	8.14	1.03e-05	5.54e-05	4|201|4|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0032468	Golgi calcium ion homeostasis	3	8.14	1.03e-05	5.54e-05	4|201|4|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0007601	visual perception	3	6.22	1.01e-05	5.54e-05	9|201|27|3527	PF00027;PF00053;PF00055;PF00350;PF00415;PF00612;PF03607;PF07719;PF13385
Group	GO:0032321	positive regulation of Rho GTPase activity	3	7.00	1.16e-05	6.06e-05	6|201|11|3527	PF00041;PF00611;PF00612;PF01404;PF06920;PF14429
Group	GO:0002026	regulation of the force of heart contraction	3	7.00	1.16e-05	6.06e-05	6|201|11|3527	PF00122;PF00169;PF00689;PF00690;PF00702;PF01699
Group	GO:0002028	regulation of sodium ion transport	3	6.58	1.30e-05	6.65e-05	7|201|16|3527	PF00122;PF00169;PF00397;PF00435;PF00689;PF00690;PF00702
Group	GO:0045834	positive regulation of lipid metabolic process	3	5.91	1.96e-05	9.77e-05	9|201|29|3527	PF00019;PF00041;PF00049;PF00169;PF00341;PF00688;PF07653;PF07679;PF12697
Group	GO:0050920	regulation of chemotaxis	3	6.32	2.10e-05	1.04e-04	7|201|17|3527	PF00019;PF00341;PF00688;PF01403;PF01437;PF01833;PF07653
Group	GO:0010717	regulation of epithelial to mesenchymal transition	3	6.94	2.78e-05	1.32e-04	5|201|8|3527	PF00019;PF00514;PF00688;PF01404;PF03165
Group	GO:0033135	regulation of peptidyl-serine phosphorylation	3	6.94	2.78e-05	1.32e-04	5|201|8|3527	PF00019;PF00169;PF00452;PF00688;PF00786
Group	GO:0007254	JNK cascade	3	6.09	3.27e-05	1.51e-04	7|201|18|3527	PF00049;PF00240;PF00640;PF00780;PF00786;PF01843;PF07653
Group	GO:0035265	organ growth	3	6.30	3.90e-05	1.77e-04	6|201|13|3527	PF00019;PF00688;PF02037;PF07679;PF12796;PF14324
Group	GO:0051238	sequestering of metal ion	3	7.17	4.90e-05	2.13e-04	4|201|5|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0055071	manganese ion homeostasis	3	7.17	4.90e-05	2.13e-04	4|201|5|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0007050	cell cycle arrest	3	5.87	4.93e-05	2.13e-04	7|201|19|3527	PF00019;PF00023;PF00350;PF00397;PF00640;PF00688;PF07645
Group	GO:0048009	insulin-like growth factor receptor signaling pathway	3	6.46	5.98e-05	2.49e-04	5|201|9|3527	PF00049;PF00169;PF00757;PF01030;PF02145
Group	GO:0045186	zonula adherens assembly	3	6.46	5.98e-05	2.49e-04	5|201|9|3527	PF00130;PF00169;PF00435;PF02828;PF07653
Group	GO:0009648	photoperiodism	3	6.46	5.98e-05	2.49e-04	5|201|9|3527	PF00076;PF00098;PF00249;PF00400;PF00989
Group	GO:0007176	regulation of epidermal growth factor-activated receptor activity	3	6.46	5.98e-05	2.49e-04	5|201|9|3527	PF00014;PF01585;PF02177;PF07525;PF12924
Group	GO:0051017	actin filament bundle assembly	3	5.53	6.21e-05	2.58e-04	8|201|26|3527	PF00611;PF00612;PF02181;PF02214;PF06367;PF06371;PF07653;PF12796
Group	GO:0008358	maternal determination of anterior/posterior axis, embryo	3	6.01	6.50e-05	2.68e-04	6|201|14|3527	PF00076;PF00622;PF00651;PF01064;PF07525;PF13091
Group	GO:0045667	regulation of osteoblast differentiation	3	5.67	7.22e-05	2.96e-04	7|201|20|3527	PF00019;PF00093;PF00514;PF00688;PF01064;PF03165;PF07645
Group	GO:0006275	regulation of DNA replication	3	5.24	1.12e-04	4.39e-04	8|201|28|3527	PF00019;PF00134;PF00341;PF00688;PF01336;PF12171;PF12756;PF12895
Group	GO:0042036	negative regulation of cytokine biosynthetic process	3	6.05	1.14e-04	4.45e-04	5|201|10|3527	PF00019;PF00023;PF00076;PF00688;PF12796
Group	GO:0032856	activation of Ras GTPase activity	3	6.45	1.40e-04	5.39e-04	4|201|6|3527	PF00041;PF00169;PF01404;PF02145
Group	GO:0060491	regulation of cell projection assembly	3	5.30	1.44e-04	5.47e-04	7|201|22|3527	PF00130;PF00612;PF00786;PF02181;PF06367;PF06371;PF12796
Group	GO:1901185	negative regulation of ERBB signaling pathway	3	5.50	1.57e-04	5.92e-04	6|201|16|3527	PF00041;PF01448;PF01585;PF07525;PF07679;PF13855
Group	GO:0007173	epidermal growth factor receptor signaling pathway	3	5.13	1.97e-04	7.15e-04	7|201|23|3527	PF00019;PF00130;PF00169;PF00688;PF00757;PF01030;PF07645
Group	GO:0048640	negative regulation of developmental growth	3	5.70	1.99e-04	7.19e-04	5|201|11|3527	PF00019;PF00611;PF00622;PF00688;PF01403
Group	GO:0007309	oocyte axis specification	3	5.28	2.32e-04	8.16e-04	6|201|17|3527	PF00076;PF00130;PF00622;PF00651;PF07525;PF13091
Group	GO:0017145	stem cell division	3	4.98	2.65e-04	9.15e-04	7|201|24|3527	PF00019;PF00076;PF00130;PF00640;PF00688;PF01064;PF03165
Group	GO:0007088	regulation of mitosis	3	4.98	2.65e-04	9.15e-04	7|201|24|3527	PF00019;PF00341;PF00688;PF02148;PF07679;PF12895;PF13414
Group	GO:0006828	manganese ion transport	3	5.88	3.13e-04	1.05e-03	4|201|7|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0010770	positive regulation of cell morphogenesis involved in differentiation	3	5.88	3.13e-04	1.05e-03	4|201|7|3527	PF00019;PF00514;PF00688;PF03165
Group	GO:0006984	ER-nucleus signaling pathway	3	4.83	3.51e-04	1.14e-03	7|201|25|3527	PF00049;PF00122;PF00226;PF00400;PF00689;PF00690;PF00702
Group	GO:0051048	negative regulation of secretion	3	4.83	3.51e-04	1.14e-03	7|201|25|3527	PF00019;PF00622;PF00688;PF01064;PF01833;PF04055;PF13765
Group	GO:0031345	negative regulation of cell projection organization	3	4.88	4.62e-04	1.47e-03	6|201|19|3527	PF00041;PF00254;PF00780;PF01403;PF01404;PF13855
Group	GO:0061136	regulation of proteasomal protein catabolic process	3	4.88	4.62e-04	1.47e-03	6|201|19|3527	PF00240;PF00400;PF00778;PF00789;PF02148;PF13414
Group	GO:0050885	neuromuscular process controlling balance	3	5.10	5.05e-04	1.58e-03	5|201|13|3527	PF00014;PF02177;PF07653;PF12796;PF12924
Group	GO:0007520	myoblast fusion	3	5.10	5.05e-04	1.58e-03	5|201|13|3527	PF00041;PF06920;PF07679;PF12796;PF13414
Group	GO:0009624	response to nematode	3	5.41	5.98e-04	1.79e-03	4|201|8|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0010594	regulation of endothelial cell migration	3	5.41	5.98e-04	1.79e-03	4|201|8|3527	PF00019;PF00130;PF00341;PF00688
Group	GO:0060997	dendritic spine morphogenesis	3	5.41	5.98e-04	1.79e-03	4|201|8|3527	PF00041;PF01404;PF07653;PF12796
Group	GO:0000186	activation of MAPKK activity	3	5.41	5.98e-04	1.79e-03	4|201|8|3527	PF00019;PF00688;PF00780;PF07653
Group	GO:0050772	positive regulation of axonogenesis	3	5.41	5.98e-04	1.79e-03	4|201|8|3527	PF01403;PF01437;PF07679;PF13855
Group	GO:0050918	positive chemotaxis	3	5.41	5.98e-04	1.79e-03	4|201|8|3527	PF00019;PF00341;PF00688;PF02145
Group	GO:0034121	regulation of toll-like receptor signaling pathway	3	5.41	5.98e-04	1.79e-03	4|201|8|3527	PF00041;PF04055;PF07679;PF12796
Group	GO:0006885	regulation of pH	3	4.70	6.28e-04	1.86e-03	6|201|20|3527	PF00122;PF00400;PF00689;PF00690;PF00702;PF01496
Group	GO:0048771	tissue remodeling	3	4.85	7.50e-04	2.12e-03	5|201|14|3527	PF00049;PF00082;PF00452;PF00688;PF01064
Group	GO:1901216	positive regulation of neuron death	3	4.85	7.50e-04	2.12e-03	5|201|14|3527	PF00041;PF00452;PF01404;PF07679;PF13716
Group	GO:0007093	mitotic cell cycle checkpoint	3	4.42	7.46e-04	2.12e-03	7|201|28|3527	PF00019;PF00134;PF00452;PF00688;PF02037;PF12796;PF14324
Group	GO:0001666	response to hypoxia	3	4.16	7.80e-04	2.18e-03	9|201|45|3527	PF00019;PF00045;PF00341;PF00413;PF00643;PF00688;PF00989;PF02145;PF13716
Group	GO:0042384	cilium assembly	3	4.53	8.38e-04	2.32e-03	6|201|21|3527	PF00400;PF00581;PF01833;PF03133;PF07719;PF13414
Group	GO:0000209	protein polyubiquitination	3	4.53	8.38e-04	2.32e-03	6|201|21|3527	PF00179;PF01485;PF02825;PF07719;PF12895;PF13414
Group	GO:0007623	circadian rhythm	3	4.30	9.36e-04	2.55e-03	7|201|29|3527	PF00027;PF00076;PF00098;PF00249;PF00583;PF00989;PF13716
Group	GO:0006878	cellular copper ion homeostasis	3	5.02	1.03e-03	2.71e-03	4|201|9|3527	PF00014;PF00702;PF02177;PF12924
Group	GO:0060428	lung epithelium development	3	5.02	1.03e-03	2.71e-03	4|201|9|3527	PF00049;PF00640;PF03165;PF07679
Group	GO:0016339	calcium-dependent cell-cell adhesion	3	5.02	1.03e-03	2.71e-03	4|201|9|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0006611	protein export from nucleus	3	5.02	1.03e-03	2.71e-03	4|201|9|3527	PF00019;PF00688;PF03810;PF08389
Group	GO:0060571	morphogenesis of an epithelial fold	3	5.02	1.03e-03	2.71e-03	4|201|9|3527	PF00130;PF00757;PF01030;PF07679
Group	GO:0043954	cellular component maintenance	3	5.02	1.03e-03	2.71e-03	4|201|9|3527	PF00169;PF00514;PF03607;PF13414
Group	GO:0002040	sprouting angiogenesis	3	5.02	1.03e-03	2.71e-03	4|201|9|3527	PF00019;PF00341;PF00688;PF12796
Group	GO:0010821	regulation of mitochondrion organization	3	5.02	1.03e-03	2.71e-03	4|201|9|3527	PF00049;PF00169;PF00452;PF12906
Group	GO:0043112	receptor metabolic process	3	4.63	1.07e-03	2.78e-03	5|201|15|3527	PF00019;PF00082;PF00169;PF00397;PF00688
Group	GO:0051340	regulation of ligase activity	3	4.63	1.07e-03	2.78e-03	5|201|15|3527	PF00023;PF00179;PF00240;PF00400;PF02148
Group	GO:0001892	embryonic placenta development	3	4.38	1.10e-03	2.83e-03	6|201|22|3527	PF00169;PF00341;PF00757;PF00989;PF01030;PF07679
Group	GO:0018108	peptidyl-tyrosine phosphorylation	3	4.38	1.10e-03	2.83e-03	6|201|22|3527	PF00041;PF00341;PF00611;PF01404;PF07645;PF07679
Group	GO:0008203	cholesterol metabolic process	3	4.42	1.49e-03	3.75e-03	5|201|16|3527	PF00014;PF00057;PF02177;PF07645;PF12924
Group	GO:0042462	eye photoreceptor cell development	3	4.42	1.49e-03	3.75e-03	5|201|16|3527	PF00415;PF00612;PF00651;PF03607;PF10409
Group	GO:0070167	regulation of biomineral tissue development	3	4.42	1.49e-03	3.75e-03	5|201|16|3527	PF00019;PF00594;PF00688;PF01064;PF07645
Group	GO:0045444	fat cell differentiation	3	4.42	1.49e-03	3.75e-03	5|201|16|3527	PF00019;PF00249;PF00389;PF00688;PF02826
Group	GO:0010464	regulation of mesenchymal cell proliferation	3	4.42	1.49e-03	3.75e-03	5|201|16|3527	PF00019;PF00341;PF00688;PF03165;PF07679
Group	GO:0035010	encapsulation of foreign target	3	4.68	1.64e-03	4.03e-03	4|201|10|3527	PF00041;PF00130;PF01404;PF10409
Group	GO:0060026	convergent extension	3	4.68	1.64e-03	4.03e-03	4|201|10|3527	PF00610;PF00778;PF02377;PF06297
Group	GO:0021954	central nervous system neuron development	3	4.68	1.64e-03	4.03e-03	4|201|10|3527	PF00041;PF01404;PF03165;PF03607
Group	GO:0090109	regulation of cell-substrate junction assembly	3	4.68	1.64e-03	4.03e-03	4|201|10|3527	PF00041;PF00341;PF01404;PF10409
Group	GO:0051784	negative regulation of nuclear division	3	4.68	1.64e-03	4.03e-03	4|201|10|3527	PF00019;PF00688;PF02148;PF07679
Group	GO:0045778	positive regulation of ossification	3	4.68	1.64e-03	4.03e-03	4|201|10|3527	PF00019;PF00688;PF01064;PF07645
Group	GO:0045161	neuronal ion channel clustering	3	5.24	1.67e-03	4.08e-03	3|201|5|3527	PF00041;PF00435;PF07679
Group	GO:0060363	cranial suture morphogenesis	3	5.24	1.67e-03	4.08e-03	3|201|5|3527	PF00019;PF00688;PF07679
Group	GO:0016197	endosomal transport	3	3.96	1.74e-03	4.22e-03	7|201|32|3527	PF00025;PF00179;PF00350;PF00397;PF02893;PF12763;PF13385
Group	GO:0050796	regulation of insulin secretion	3	4.09	1.80e-03	4.34e-03	6|201|24|3527	PF00019;PF00027;PF00688;PF00969;PF01064;PF02214
Group	GO:0006818	hydrogen transport	3	4.23	2.01e-03	4.80e-03	5|201|17|3527	PF00122;PF00153;PF00690;PF00702;PF01496
Group	GO:0045732	positive regulation of protein catabolic process	3	4.23	2.01e-03	4.80e-03	5|201|17|3527	PF00397;PF00400;PF00514;PF00778;PF07525
Group	GO:0008586	imaginal disc-derived wing vein morphogenesis	3	4.39	2.46e-03	5.66e-03	4|201|11|3527	PF00397;PF00612;PF01448;PF07645
Group	GO:0001938	positive regulation of endothelial cell proliferation	3	4.39	2.46e-03	5.66e-03	4|201|11|3527	PF00019;PF00130;PF00341;PF00688
Group	GO:0009950	dorsal/ventral axis specification	3	4.39	2.46e-03	5.66e-03	4|201|11|3527	PF00057;PF00076;PF00778;PF03165
Group	GO:0048730	epidermis morphogenesis	3	4.39	2.46e-03	5.66e-03	4|201|11|3527	PF00019;PF00688;PF01843;PF07679
Group	GO:0006582	melanin metabolic process	3	4.39	2.46e-03	5.66e-03	4|201|11|3527	PF00041;PF00130;PF01404;PF10409
Group	GO:0090114	COPII-coated vesicle budding	3	4.39	2.46e-03	5.66e-03	4|201|11|3527	PF00400;PF00651;PF04810;PF07707
Group	GO:0022405	hair cycle process	3	4.05	2.66e-03	6.01e-03	5|201|18|3527	PF00019;PF00688;PF00757;PF01030;PF07679
Group	GO:0061099	negative regulation of protein tyrosine kinase activity	3	4.68	3.21e-03	7.05e-03	3|201|6|3527	PF00400;PF01585;PF07525
Group	GO:0035001	dorsal trunk growth, open tracheal system	3	4.68	3.21e-03	7.05e-03	3|201|6|3527	PF00057;PF02828;PF07653
Group	GO:0002467	germinal center formation	3	4.68	3.21e-03	7.05e-03	3|201|6|3527	PF00023;PF00651;PF12796
Group	GO:0048669	collateral sprouting in absence of injury	3	4.68	3.21e-03	7.05e-03	3|201|6|3527	PF00014;PF02177;PF12924
Group	GO:0043555	regulation of translation in response to stress	3	4.68	3.21e-03	7.05e-03	3|201|6|3527	PF00076;PF00098;PF05773
Group	GO:0001649	osteoblast differentiation	3	3.89	3.45e-03	7.48e-03	5|201|19|3527	PF00019;PF00093;PF00688;PF03165;PF13716
Group	GO:0000082	G1/S transition of mitotic cell cycle	3	3.89	3.45e-03	7.48e-03	5|201|19|3527	PF00019;PF00023;PF00134;PF00688;PF01833
Group	GO:0021536	diencephalon development	3	3.89	3.45e-03	7.48e-03	5|201|19|3527	PF00019;PF00249;PF00688;PF01064;PF07679
Group	GO:0051092	positive regulation of NF-kappaB transcription factor activity	3	3.72	3.43e-03	7.48e-03	6|201|27|3527	PF00023;PF00130;PF00169;PF00899;PF12796;PF13855
Group	GO:0001935	endothelial cell proliferation	3	4.14	3.53e-03	7.58e-03	4|201|12|3527	PF00019;PF00688;PF05485;PF07653
Group	GO:0019722	calcium-mediated signaling	3	4.14	3.53e-03	7.58e-03	4|201|12|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0072012	glomerulus vasculature development	3	4.14	3.53e-03	7.58e-03	4|201|12|3527	PF00019;PF00341;PF00688;PF07679
Group	GO:0045931	positive regulation of mitotic cell cycle	3	3.73	4.39e-03	9.35e-03	5|201|20|3527	PF00014;PF00130;PF01448;PF02177;PF12924
Group	GO:0018095	protein polyglutamylation	4	8.14	1.03e-05	5.54e-05	4|201|4|3527	PF00581;PF03133;PF07719;PF13414
Group	GO:0070979	protein K11-linked ubiquitination	4	5.88	3.13e-04	1.05e-03	4|201|7|3527	PF00179;PF07719;PF12895;PF13414
Group	GO:0034122	negative regulation of toll-like receptor signaling pathway	4	5.98	6.99e-04	2.01e-03	3|201|4|3527	PF00041;PF07679;PF12796
Group	GO:0010862	positive regulation of pathway-restricted SMAD protein phosphorylation	4	5.98	6.99e-04	2.01e-03	3|201|4|3527	PF00019;PF00688;PF01064
Group	GO:0033138	positive regulation of peptidyl-serine phosphorylation	4	5.98	6.99e-04	2.01e-03	3|201|4|3527	PF00019;PF00688;PF00786
Group	GO:0031145	anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process	4	5.98	6.99e-04	2.01e-03	3|201|4|3527	PF00179;PF12895;PF13414
Group	GO:0007183	SMAD protein complex assembly	4	5.98	6.99e-04	2.01e-03	3|201|4|3527	PF00019;PF00688;PF03165
Group	GO:0008053	mitochondrial fusion	4	5.98	6.99e-04	2.01e-03	3|201|4|3527	PF00350;PF00452;PF13091
Group	GO:0045648	positive regulation of erythrocyte differentiation	4	5.24	1.67e-03	4.08e-03	3|201|5|3527	PF00019;PF00688;PF12796
Group	GO:0001974	blood vessel remodeling	4	4.68	3.21e-03	7.05e-03	3|201|6|3527	PF00049;PF00452;PF01064
